+Follow
GangKK
No personal profile
2
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
GangKK
2022-12-13
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-12-09
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-12-06
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-12-05
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-12-04
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-12-02
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-30
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-29
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-28
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-27
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-25
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-19
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-16
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-15
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-14
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-13
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-12
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-11
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-10
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
GangKK
2022-11-09
$Novavax(NVAX)$
[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4090807166052950","uuid":"4090807166052950","gmtCreate":1627706322608,"gmtModify":1627706322608,"name":"GangKK","pinyin":"gangkk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":2,"tweetSize":210,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.03","exceedPercentage":"80.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.16","exceedPercentage":"60.09%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9923270912,"gmtCreate":1670880695537,"gmtModify":1676538450353,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9923270912","isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9920570923,"gmtCreate":1670535249463,"gmtModify":1676538386317,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9920570923","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9967362409,"gmtCreate":1670276221102,"gmtModify":1676538332908,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9967362409","isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9964569478,"gmtCreate":1670189908295,"gmtModify":1676538314766,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9964569478","isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9964148077,"gmtCreate":1670114707600,"gmtModify":1676538303563,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9964148077","isVote":1,"tweetType":1,"viewCount":448,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9965805361,"gmtCreate":1669930575954,"gmtModify":1676538270715,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9965805361","isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9962831276,"gmtCreate":1669757743896,"gmtModify":1676538235500,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9962831276","isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9966742981,"gmtCreate":1669671469143,"gmtModify":1676538219557,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9966742981","isVote":1,"tweetType":1,"viewCount":326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9966245015,"gmtCreate":1669584964937,"gmtModify":1676538208315,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9966245015","isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9966294566,"gmtCreate":1669542347156,"gmtModify":1676538206188,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9966294566","isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9968799100,"gmtCreate":1669326078401,"gmtModify":1676538182171,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9968799100","isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9961963353,"gmtCreate":1668820915872,"gmtModify":1676538117667,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9961963353","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9969770443,"gmtCreate":1668547971183,"gmtModify":1676538072204,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969770443","isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9969233732,"gmtCreate":1668461643827,"gmtModify":1676538058190,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969233732","isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9969323836,"gmtCreate":1668375462525,"gmtModify":1676538044897,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969323836","isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9960770141,"gmtCreate":1668292180183,"gmtModify":1676538036292,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9960770141","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9960516287,"gmtCreate":1668209362449,"gmtModify":1676538027849,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9960516287","isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9960124975,"gmtCreate":1668116341298,"gmtModify":1676538013505,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9960124975","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9960038165,"gmtCreate":1668029567558,"gmtModify":1676537999163,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9960038165","isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9987246031,"gmtCreate":1667943657824,"gmtModify":1676537986304,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9987246031","isVote":1,"tweetType":1,"viewCount":138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9984878465,"gmtCreate":1667611016857,"gmtModify":1676537943695,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"Noted ","listText":"Noted ","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9984878465","repostId":"2281680644","repostType":4,"repost":{"id":"2281680644","kind":"highlight","pubTimestamp":1667603225,"share":"https://ttm.financial/m/news/2281680644?lang=&edition=fundamental","pubTime":"2022-11-05 07:07","market":"us","language":"en","title":"US STOCKS-Wall St Rallies to Close Out Soft Week After Jobs Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2281680644","media":"Reuters","summary":"Data shows strong jobs growth, uptick in jobless rateStarbucks, DoorDash jump on upbeat resultsU.S-listed China firms rise on reopening hopesDow up 1.26%, S&P 500 up 1.36%, Nasdaq up 1.28%U.S. stocks ","content":"<html><head></head><body><ul><li>Data shows strong jobs growth, uptick in jobless rate</li><li>Starbucks, DoorDash jump on upbeat results</li><li>U.S-listed China firms rise on reopening hopes</li><li>Dow up 1.26%, S&P 500 up 1.36%, Nasdaq up 1.28%</li></ul><p>U.S. stocks closed higher on Friday in volatile trade to snap a four-session losing streak as investors wrestled with a mixed jobs report and comments from Federal Reserve officials on the pace of interest rate hikes.</p><p>The S&P 500 and the Nasdaq each rose as much as 2% in the early stages of trading while the Dow Jones Industrial Average climbed as much as 1.9% on the heels of the closely watched labor market report, before paring gains and briefly falling into negative territory. The report showed an uptick in the unemployment rate in October, indicating some signs of slack may finally be starting to emerge in the job market and give the Fed room to downsize its rate hikes beginning in December.</p><p>But the data also showed average hourly earnings rose slightly more than expected, as did job growth, pointing to a labor market that largely remains on firm footing.</p><p>Labor market data has been a primary focus for markets as the Fed has repeatedly stated it is looking for some cooling before considering a pause in hikes. Hawkish comments from Fed Chair Jerome Powell on Wednesday increased worries the central bank could keep boosting interest rates for longer than previously expected and put further pressure on stocks.</p><p>"This was not a report that shows the rate hikes are starting to take hold," said Shawn Cruz, head trading strategist at TD Ameritrade in Chicago.</p><p>"You could maybe justify some of this move as this selling got a little overdone after what Powell said at the meeting, so maybe you already had the sellers flushed out."</p><p>On Friday, Fed officials echoed Powell's comments about potentially decreasing the size of rate hikes in the future, but needing to continue to raise rates for a longer period of time and potentially above the 4.6% level the central bank penciled in at its September meeting.</p><p>Equities got a boost late in the session after Chicago Fed President Charles Evans said it was possible for the Fed to be "thinking" about pausing even if it's a year from now.</p><p>The Dow Jones Industrial Average rose 401.97 points, or 1.26%, to 32,403.22, the S&P 500 gained 50.66 points, or 1.36%, to 3,770.55 and the Nasdaq Composite added 132.31 points, or 1.28%, to 10,475.25.</p><p>For the week, the Dow fell 1.39% to snap a four-week winning streak, the S&P dropped 3.34% and the Nasdaq slid 5.65% for its biggest weekly percentage decline since January.</p><p>The non-farm payrolls report comes after a conflicting set of data this week that pointed to a slowdown in certain parts of the economy but also underscored the resilience of the U.S. labor market despite aggressive rate hikes to tame inflation.</p><p>Traders' expectations of a 75 basis point rate hike in December had briefly jumped after the jobs report but were now pricing in about a 62% chance of a 50 basis point hike, according to CME's FedWatch Tool.</p><p>Market focus will now turn to a key consumer inflation reading due next week as well as the U.S. midterm elections on Nov. 8, where control of Congress is at stake.</p><p>Meanwhile, hopes of an easing in China's tough COVID-19 curbs supported some areas of the market, with U.S.-listed shares of Chinese companies including Alibaba, which finished up 7.05% and JD.com, up 9.74%.</p><p>Those hopes also helped boost prices of commodities such as copper, which in turn lifted the materials sector 3.41% as the best performing of the 11 major S&P sectors.</p><p>Starbucks Corp jumped 8.48% after it topped Wall Street estimates for quarterly comparable sales and profit, while DoorDash Inc's revenue beat boosted the food delivery firm's shares by 8.32%.</p><p>Volume on U.S. exchanges was 13.31 billion shares, compared with the 11.74 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 2.56-to-1 ratio; on Nasdaq, a 1.41-to-1 ratio favored advancers.</p><p>The S&P 500 posted 18 new 52-week highs and 27 new lows; the Nasdaq Composite recorded 81 new highs and 278 new lows.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall St Rallies to Close Out Soft Week After Jobs Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall St Rallies to Close Out Soft Week After Jobs Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-05 07:07 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-wall-st-rallies-202354523.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Data shows strong jobs growth, uptick in jobless rateStarbucks, DoorDash jump on upbeat resultsU.S-listed China firms rise on reopening hopesDow up 1.26%, S&P 500 up 1.36%, Nasdaq up 1.28%U.S. stocks ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-rallies-202354523.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-rallies-202354523.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2281680644","content_text":"Data shows strong jobs growth, uptick in jobless rateStarbucks, DoorDash jump on upbeat resultsU.S-listed China firms rise on reopening hopesDow up 1.26%, S&P 500 up 1.36%, Nasdaq up 1.28%U.S. stocks closed higher on Friday in volatile trade to snap a four-session losing streak as investors wrestled with a mixed jobs report and comments from Federal Reserve officials on the pace of interest rate hikes.The S&P 500 and the Nasdaq each rose as much as 2% in the early stages of trading while the Dow Jones Industrial Average climbed as much as 1.9% on the heels of the closely watched labor market report, before paring gains and briefly falling into negative territory. The report showed an uptick in the unemployment rate in October, indicating some signs of slack may finally be starting to emerge in the job market and give the Fed room to downsize its rate hikes beginning in December.But the data also showed average hourly earnings rose slightly more than expected, as did job growth, pointing to a labor market that largely remains on firm footing.Labor market data has been a primary focus for markets as the Fed has repeatedly stated it is looking for some cooling before considering a pause in hikes. Hawkish comments from Fed Chair Jerome Powell on Wednesday increased worries the central bank could keep boosting interest rates for longer than previously expected and put further pressure on stocks.\"This was not a report that shows the rate hikes are starting to take hold,\" said Shawn Cruz, head trading strategist at TD Ameritrade in Chicago.\"You could maybe justify some of this move as this selling got a little overdone after what Powell said at the meeting, so maybe you already had the sellers flushed out.\"On Friday, Fed officials echoed Powell's comments about potentially decreasing the size of rate hikes in the future, but needing to continue to raise rates for a longer period of time and potentially above the 4.6% level the central bank penciled in at its September meeting.Equities got a boost late in the session after Chicago Fed President Charles Evans said it was possible for the Fed to be \"thinking\" about pausing even if it's a year from now.The Dow Jones Industrial Average rose 401.97 points, or 1.26%, to 32,403.22, the S&P 500 gained 50.66 points, or 1.36%, to 3,770.55 and the Nasdaq Composite added 132.31 points, or 1.28%, to 10,475.25.For the week, the Dow fell 1.39% to snap a four-week winning streak, the S&P dropped 3.34% and the Nasdaq slid 5.65% for its biggest weekly percentage decline since January.The non-farm payrolls report comes after a conflicting set of data this week that pointed to a slowdown in certain parts of the economy but also underscored the resilience of the U.S. labor market despite aggressive rate hikes to tame inflation.Traders' expectations of a 75 basis point rate hike in December had briefly jumped after the jobs report but were now pricing in about a 62% chance of a 50 basis point hike, according to CME's FedWatch Tool.Market focus will now turn to a key consumer inflation reading due next week as well as the U.S. midterm elections on Nov. 8, where control of Congress is at stake.Meanwhile, hopes of an easing in China's tough COVID-19 curbs supported some areas of the market, with U.S.-listed shares of Chinese companies including Alibaba, which finished up 7.05% and JD.com, up 9.74%.Those hopes also helped boost prices of commodities such as copper, which in turn lifted the materials sector 3.41% as the best performing of the 11 major S&P sectors.Starbucks Corp jumped 8.48% after it topped Wall Street estimates for quarterly comparable sales and profit, while DoorDash Inc's revenue beat boosted the food delivery firm's shares by 8.32%.Volume on U.S. exchanges was 13.31 billion shares, compared with the 11.74 billion average for the full session over the last 20 trading days.Advancing issues outnumbered declining ones on the NYSE by a 2.56-to-1 ratio; on Nasdaq, a 1.41-to-1 ratio favored advancers.The S&P 500 posted 18 new 52-week highs and 27 new lows; the Nasdaq Composite recorded 81 new highs and 278 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066149063,"gmtCreate":1651881122953,"gmtModify":1676534988230,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Sad] [Sad] [Sad] ","listText":"[Sad] [Sad] [Sad] ","text":"[Sad] [Sad] [Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066149063","repostId":"2233939112","repostType":4,"repost":{"id":"2233939112","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1651879296,"share":"https://ttm.financial/m/news/2233939112?lang=&edition=fundamental","pubTime":"2022-05-07 07:21","market":"us","language":"en","title":"US STOCKS-Wall Street Ends Down on Fears Inflation Will Force Tougher Fed Tightening","url":"https://stock-news.laohu8.com/highlight/detail?id=2233939112","media":"Reuters","summary":"Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve w","content":"<html><head></head><body><p>Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve will need to be more aggressive than expected in raising interest rates to combat inflation.</p><p>The tech-heavy Nasdaq registered its lowest close since 2020, notching a fifth straight weekly loss, its longest losing streak since the fourth quarter of 2012. The S&P 500 also posted its fifth straight weekly loss, its longest string of weekly losses since the second quarter of 2011.</p><p>"Ninety-five percent of the driver of the market right now is long-term interest rates," said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York.</p><p>The Labor Department presented stronger-than-expected jobs data with nonfarm payrolls increasing by 428,000 jobs in April, versus expectations of 391,000 job additions, underscoring the economy's strong fundamentals despite a contraction in gross domestic product in the first quarter.</p><p>The unemployment rate remained unchanged at 3.6% in the month, while average hourly earnings increased 0.3% against a forecast of a 0.4% rise.</p><p>Nine of the 11 major S&P sectors declined. Energy had a 2.9% gain as oil prices climbed on supply concerns.</p><p>"Oil is up again, continuing the inflationary worries that we are seeing and energy is bucking the trend of a very weak market. But the higher natural gas and crude oil prices have been tailwinds for the energy sector this year," said Ryan Detrick, chief market strategist for LPL Financial.</p><p>Megacap growth stocks slipped, with a few exceptions including Apple Inc, which rose 0.5%. Wells Fargo & Co declined 0.5% to lead losses among big banks.</p><p>The Dow Jones Industrial Average fell 98.6 points, or 0.3%, to 32,899.37, the S&P 500 lost 23.53 points, or 0.57%, to 4,123.34 and the Nasdaq Composite dropped 173.03 points, or 1.4%, to 12,144.66.</p><p>Most traders are expecting a 75 basis-point hike at the U.S. central bank's June meeting, despite Fed chief Jerome Powell's ruling that out.</p><p>All eyes are on the monthly consumer price index inflation report on Wednesday, as investors seek clues to whether the economy is nearing a peak in inflation.</p><p>Under Armour Inc slumped 23.8% after the sportswear maker forecast downbeat fiscal 2023 profit. Shares of rival Nike Inc also slipped.</p><p>Coinbase Global Inc dropped 9% on Friday to the lowest level since the cryptocurrency exchange's 2021 stock market debut.</p><p>Volume on U.S. exchanges was 13.49 billion shares, compared with the 12.10 billion average for the full session over the last 20 trading days.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 3.04-to-1 ratio favored decliners.</p><p>The S&P 500 posted <a href=\"https://laohu8.com/S/AONE.U\">one</a> new 52-week high and 63 new lows; the Nasdaq Composite recorded 15 new highs and 799 new lows.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street Ends Down on Fears Inflation Will Force Tougher Fed Tightening</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street Ends Down on Fears Inflation Will Force Tougher Fed Tightening\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-05-07 07:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve will need to be more aggressive than expected in raising interest rates to combat inflation.</p><p>The tech-heavy Nasdaq registered its lowest close since 2020, notching a fifth straight weekly loss, its longest losing streak since the fourth quarter of 2012. The S&P 500 also posted its fifth straight weekly loss, its longest string of weekly losses since the second quarter of 2011.</p><p>"Ninety-five percent of the driver of the market right now is long-term interest rates," said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York.</p><p>The Labor Department presented stronger-than-expected jobs data with nonfarm payrolls increasing by 428,000 jobs in April, versus expectations of 391,000 job additions, underscoring the economy's strong fundamentals despite a contraction in gross domestic product in the first quarter.</p><p>The unemployment rate remained unchanged at 3.6% in the month, while average hourly earnings increased 0.3% against a forecast of a 0.4% rise.</p><p>Nine of the 11 major S&P sectors declined. Energy had a 2.9% gain as oil prices climbed on supply concerns.</p><p>"Oil is up again, continuing the inflationary worries that we are seeing and energy is bucking the trend of a very weak market. But the higher natural gas and crude oil prices have been tailwinds for the energy sector this year," said Ryan Detrick, chief market strategist for LPL Financial.</p><p>Megacap growth stocks slipped, with a few exceptions including Apple Inc, which rose 0.5%. Wells Fargo & Co declined 0.5% to lead losses among big banks.</p><p>The Dow Jones Industrial Average fell 98.6 points, or 0.3%, to 32,899.37, the S&P 500 lost 23.53 points, or 0.57%, to 4,123.34 and the Nasdaq Composite dropped 173.03 points, or 1.4%, to 12,144.66.</p><p>Most traders are expecting a 75 basis-point hike at the U.S. central bank's June meeting, despite Fed chief Jerome Powell's ruling that out.</p><p>All eyes are on the monthly consumer price index inflation report on Wednesday, as investors seek clues to whether the economy is nearing a peak in inflation.</p><p>Under Armour Inc slumped 23.8% after the sportswear maker forecast downbeat fiscal 2023 profit. Shares of rival Nike Inc also slipped.</p><p>Coinbase Global Inc dropped 9% on Friday to the lowest level since the cryptocurrency exchange's 2021 stock market debut.</p><p>Volume on U.S. exchanges was 13.49 billion shares, compared with the 12.10 billion average for the full session over the last 20 trading days.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 3.04-to-1 ratio favored decliners.</p><p>The S&P 500 posted <a href=\"https://laohu8.com/S/AONE.U\">one</a> new 52-week high and 63 new lows; the Nasdaq Composite recorded 15 new highs and 799 new lows.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","BK4504":"桥水持仓","SPY":"标普500ETF","QQQ":"纳指100ETF","DXD":"道指两倍做空ETF","SDS":"两倍做空标普500ETF","DJX":"1/100道琼斯","SDOW":"道指三倍做空ETF-ProShares","QID":"纳指两倍做空ETF","DDM":"道指两倍做多ETF","UPRO":"三倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","BK4534":"瑞士信贷持仓","LHDX":"Lucira Health, Inc.","IVV":"标普500指数ETF","SH":"标普500反向ETF","BK4139":"生物科技","DOG":"道指反向ETF","BK4007":"制药","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","BK4196":"保健护理服务","APR":"Apria, Inc.","BK4082":"医疗保健设备","BK4559":"巴菲特持仓",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","SSO":"两倍做多标普500ETF","CGEM":"Cullinan Therapeutics",".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓","LABP":"Landos Biopharma, Inc.","OEX":"标普100",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","OEF":"标普100指数ETF-iShares","SANA":"Sana Biotechnology, Inc.","BK4581":"高盛持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2233939112","content_text":"Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve will need to be more aggressive than expected in raising interest rates to combat inflation.The tech-heavy Nasdaq registered its lowest close since 2020, notching a fifth straight weekly loss, its longest losing streak since the fourth quarter of 2012. The S&P 500 also posted its fifth straight weekly loss, its longest string of weekly losses since the second quarter of 2011.\"Ninety-five percent of the driver of the market right now is long-term interest rates,\" said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York.The Labor Department presented stronger-than-expected jobs data with nonfarm payrolls increasing by 428,000 jobs in April, versus expectations of 391,000 job additions, underscoring the economy's strong fundamentals despite a contraction in gross domestic product in the first quarter.The unemployment rate remained unchanged at 3.6% in the month, while average hourly earnings increased 0.3% against a forecast of a 0.4% rise.Nine of the 11 major S&P sectors declined. Energy had a 2.9% gain as oil prices climbed on supply concerns.\"Oil is up again, continuing the inflationary worries that we are seeing and energy is bucking the trend of a very weak market. But the higher natural gas and crude oil prices have been tailwinds for the energy sector this year,\" said Ryan Detrick, chief market strategist for LPL Financial.Megacap growth stocks slipped, with a few exceptions including Apple Inc, which rose 0.5%. Wells Fargo & Co declined 0.5% to lead losses among big banks.The Dow Jones Industrial Average fell 98.6 points, or 0.3%, to 32,899.37, the S&P 500 lost 23.53 points, or 0.57%, to 4,123.34 and the Nasdaq Composite dropped 173.03 points, or 1.4%, to 12,144.66.Most traders are expecting a 75 basis-point hike at the U.S. central bank's June meeting, despite Fed chief Jerome Powell's ruling that out.All eyes are on the monthly consumer price index inflation report on Wednesday, as investors seek clues to whether the economy is nearing a peak in inflation.Under Armour Inc slumped 23.8% after the sportswear maker forecast downbeat fiscal 2023 profit. Shares of rival Nike Inc also slipped.Coinbase Global Inc dropped 9% on Friday to the lowest level since the cryptocurrency exchange's 2021 stock market debut.Volume on U.S. exchanges was 13.49 billion shares, compared with the 12.10 billion average for the full session over the last 20 trading days.Declining issues outnumbered advancing ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 3.04-to-1 ratio favored decliners.The S&P 500 posted one new 52-week high and 63 new lows; the Nasdaq Composite recorded 15 new highs and 799 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066154762,"gmtCreate":1651881017956,"gmtModify":1676534988175,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Sad] [Sad] [Sad] ","listText":"[Sad] [Sad] [Sad] ","text":"[Sad] [Sad] [Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066154762","repostId":"2233939112","repostType":4,"repost":{"id":"2233939112","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1651879296,"share":"https://ttm.financial/m/news/2233939112?lang=&edition=fundamental","pubTime":"2022-05-07 07:21","market":"us","language":"en","title":"US STOCKS-Wall Street Ends Down on Fears Inflation Will Force Tougher Fed Tightening","url":"https://stock-news.laohu8.com/highlight/detail?id=2233939112","media":"Reuters","summary":"Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve w","content":"<html><head></head><body><p>Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve will need to be more aggressive than expected in raising interest rates to combat inflation.</p><p>The tech-heavy Nasdaq registered its lowest close since 2020, notching a fifth straight weekly loss, its longest losing streak since the fourth quarter of 2012. The S&P 500 also posted its fifth straight weekly loss, its longest string of weekly losses since the second quarter of 2011.</p><p>"Ninety-five percent of the driver of the market right now is long-term interest rates," said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York.</p><p>The Labor Department presented stronger-than-expected jobs data with nonfarm payrolls increasing by 428,000 jobs in April, versus expectations of 391,000 job additions, underscoring the economy's strong fundamentals despite a contraction in gross domestic product in the first quarter.</p><p>The unemployment rate remained unchanged at 3.6% in the month, while average hourly earnings increased 0.3% against a forecast of a 0.4% rise.</p><p>Nine of the 11 major S&P sectors declined. Energy had a 2.9% gain as oil prices climbed on supply concerns.</p><p>"Oil is up again, continuing the inflationary worries that we are seeing and energy is bucking the trend of a very weak market. But the higher natural gas and crude oil prices have been tailwinds for the energy sector this year," said Ryan Detrick, chief market strategist for LPL Financial.</p><p>Megacap growth stocks slipped, with a few exceptions including Apple Inc, which rose 0.5%. Wells Fargo & Co declined 0.5% to lead losses among big banks.</p><p>The Dow Jones Industrial Average fell 98.6 points, or 0.3%, to 32,899.37, the S&P 500 lost 23.53 points, or 0.57%, to 4,123.34 and the Nasdaq Composite dropped 173.03 points, or 1.4%, to 12,144.66.</p><p>Most traders are expecting a 75 basis-point hike at the U.S. central bank's June meeting, despite Fed chief Jerome Powell's ruling that out.</p><p>All eyes are on the monthly consumer price index inflation report on Wednesday, as investors seek clues to whether the economy is nearing a peak in inflation.</p><p>Under Armour Inc slumped 23.8% after the sportswear maker forecast downbeat fiscal 2023 profit. Shares of rival Nike Inc also slipped.</p><p>Coinbase Global Inc dropped 9% on Friday to the lowest level since the cryptocurrency exchange's 2021 stock market debut.</p><p>Volume on U.S. exchanges was 13.49 billion shares, compared with the 12.10 billion average for the full session over the last 20 trading days.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 3.04-to-1 ratio favored decliners.</p><p>The S&P 500 posted <a href=\"https://laohu8.com/S/AONE.U\">one</a> new 52-week high and 63 new lows; the Nasdaq Composite recorded 15 new highs and 799 new lows.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street Ends Down on Fears Inflation Will Force Tougher Fed Tightening</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street Ends Down on Fears Inflation Will Force Tougher Fed Tightening\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-05-07 07:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve will need to be more aggressive than expected in raising interest rates to combat inflation.</p><p>The tech-heavy Nasdaq registered its lowest close since 2020, notching a fifth straight weekly loss, its longest losing streak since the fourth quarter of 2012. The S&P 500 also posted its fifth straight weekly loss, its longest string of weekly losses since the second quarter of 2011.</p><p>"Ninety-five percent of the driver of the market right now is long-term interest rates," said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York.</p><p>The Labor Department presented stronger-than-expected jobs data with nonfarm payrolls increasing by 428,000 jobs in April, versus expectations of 391,000 job additions, underscoring the economy's strong fundamentals despite a contraction in gross domestic product in the first quarter.</p><p>The unemployment rate remained unchanged at 3.6% in the month, while average hourly earnings increased 0.3% against a forecast of a 0.4% rise.</p><p>Nine of the 11 major S&P sectors declined. Energy had a 2.9% gain as oil prices climbed on supply concerns.</p><p>"Oil is up again, continuing the inflationary worries that we are seeing and energy is bucking the trend of a very weak market. But the higher natural gas and crude oil prices have been tailwinds for the energy sector this year," said Ryan Detrick, chief market strategist for LPL Financial.</p><p>Megacap growth stocks slipped, with a few exceptions including Apple Inc, which rose 0.5%. Wells Fargo & Co declined 0.5% to lead losses among big banks.</p><p>The Dow Jones Industrial Average fell 98.6 points, or 0.3%, to 32,899.37, the S&P 500 lost 23.53 points, or 0.57%, to 4,123.34 and the Nasdaq Composite dropped 173.03 points, or 1.4%, to 12,144.66.</p><p>Most traders are expecting a 75 basis-point hike at the U.S. central bank's June meeting, despite Fed chief Jerome Powell's ruling that out.</p><p>All eyes are on the monthly consumer price index inflation report on Wednesday, as investors seek clues to whether the economy is nearing a peak in inflation.</p><p>Under Armour Inc slumped 23.8% after the sportswear maker forecast downbeat fiscal 2023 profit. Shares of rival Nike Inc also slipped.</p><p>Coinbase Global Inc dropped 9% on Friday to the lowest level since the cryptocurrency exchange's 2021 stock market debut.</p><p>Volume on U.S. exchanges was 13.49 billion shares, compared with the 12.10 billion average for the full session over the last 20 trading days.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 3.04-to-1 ratio favored decliners.</p><p>The S&P 500 posted <a href=\"https://laohu8.com/S/AONE.U\">one</a> new 52-week high and 63 new lows; the Nasdaq Composite recorded 15 new highs and 799 new lows.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","BK4504":"桥水持仓","SPY":"标普500ETF","QQQ":"纳指100ETF","DXD":"道指两倍做空ETF","SDS":"两倍做空标普500ETF","DJX":"1/100道琼斯","SDOW":"道指三倍做空ETF-ProShares","QID":"纳指两倍做空ETF","DDM":"道指两倍做多ETF","UPRO":"三倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","BK4534":"瑞士信贷持仓","LHDX":"Lucira Health, Inc.","IVV":"标普500指数ETF","SH":"标普500反向ETF","BK4139":"生物科技","DOG":"道指反向ETF","BK4007":"制药","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","BK4196":"保健护理服务","APR":"Apria, Inc.","BK4082":"医疗保健设备","BK4559":"巴菲特持仓",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","SSO":"两倍做多标普500ETF","CGEM":"Cullinan Therapeutics",".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓","LABP":"Landos Biopharma, Inc.","OEX":"标普100",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","OEF":"标普100指数ETF-iShares","SANA":"Sana Biotechnology, Inc.","BK4581":"高盛持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2233939112","content_text":"Wall Street's main indexes extended losses on Friday as investors worried that the Federal Reserve will need to be more aggressive than expected in raising interest rates to combat inflation.The tech-heavy Nasdaq registered its lowest close since 2020, notching a fifth straight weekly loss, its longest losing streak since the fourth quarter of 2012. The S&P 500 also posted its fifth straight weekly loss, its longest string of weekly losses since the second quarter of 2011.\"Ninety-five percent of the driver of the market right now is long-term interest rates,\" said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York.The Labor Department presented stronger-than-expected jobs data with nonfarm payrolls increasing by 428,000 jobs in April, versus expectations of 391,000 job additions, underscoring the economy's strong fundamentals despite a contraction in gross domestic product in the first quarter.The unemployment rate remained unchanged at 3.6% in the month, while average hourly earnings increased 0.3% against a forecast of a 0.4% rise.Nine of the 11 major S&P sectors declined. Energy had a 2.9% gain as oil prices climbed on supply concerns.\"Oil is up again, continuing the inflationary worries that we are seeing and energy is bucking the trend of a very weak market. But the higher natural gas and crude oil prices have been tailwinds for the energy sector this year,\" said Ryan Detrick, chief market strategist for LPL Financial.Megacap growth stocks slipped, with a few exceptions including Apple Inc, which rose 0.5%. Wells Fargo & Co declined 0.5% to lead losses among big banks.The Dow Jones Industrial Average fell 98.6 points, or 0.3%, to 32,899.37, the S&P 500 lost 23.53 points, or 0.57%, to 4,123.34 and the Nasdaq Composite dropped 173.03 points, or 1.4%, to 12,144.66.Most traders are expecting a 75 basis-point hike at the U.S. central bank's June meeting, despite Fed chief Jerome Powell's ruling that out.All eyes are on the monthly consumer price index inflation report on Wednesday, as investors seek clues to whether the economy is nearing a peak in inflation.Under Armour Inc slumped 23.8% after the sportswear maker forecast downbeat fiscal 2023 profit. Shares of rival Nike Inc also slipped.Coinbase Global Inc dropped 9% on Friday to the lowest level since the cryptocurrency exchange's 2021 stock market debut.Volume on U.S. exchanges was 13.49 billion shares, compared with the 12.10 billion average for the full session over the last 20 trading days.Declining issues outnumbered advancing ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 3.04-to-1 ratio favored decliners.The S&P 500 posted one new 52-week high and 63 new lows; the Nasdaq Composite recorded 15 new highs and 799 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9046596796,"gmtCreate":1656370904316,"gmtModify":1676535813468,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046596796","repostId":"2246803790","repostType":2,"repost":{"id":"2246803790","kind":"highlight","pubTimestamp":1656382573,"share":"https://ttm.financial/m/news/2246803790?lang=&edition=fundamental","pubTime":"2022-06-28 10:16","market":"us","language":"en","title":"3 Reasons to Buy Novavax and 1 to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2246803790","media":"Motley Fool","summary":"What does the future hold for this COVID-19 vaccination stock?","content":"<html><head></head><body><p><b>Novavax</b> is a pandemic stock. That's why it soared in 2020-21 when the world faced the worst pandemic since the influenza outbreak of 1918. When COVID-19 hit, this vaccine biotech made an almost impossible run, from a low of $4 a share all the way to $330.</p><p>Now it's down to $50, and the company's market cap is under $4 billion. Is it a buy at these prices? Here are three arguments for buying Novavax stock and one reason for why you might want to avoid these shares.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a59fcd638ddc65fc898da7b619b04516\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>Green Flag #1: Huge revenue in 2022 plus profits!</h2><p>In the first quarter, Novavax reported its first profitable quarter as a public company, with $200 million in profits off of $700 million in sales. That's a huge step up for a biotech, which has been unprofitable since it hit the public markets way back in the 20th century (1995 to be exact).</p><p>Novavax is a scrappy underdog that has survived for almost three decades without making any money. When Stan Erck arrived at the CEO slot in 2011, the company turned its focus toward vaccines to thwart pandemics. So if you're worried about severe acute respiratory syndrome (SARS), Novavax has discovered a potential vaccine for that. The biotech also has vaccine candidates in its pipeline for Ebola, malaria, Middle East respiratory syndrome (MERS), and influenza.</p><p>None of those drugs have been approved yet (Novavax is still waiting for its first FDA approval), but all of this scientific research gave the small biotech a big advantage when it came to combating the new coronavirus that hit the world two years ago. Based on its research, Novavax was awarded a massive $399 million check from the Bill Gates-funded Coalition for Epidemic Preparedness Innovations (CEPI). It's still the largest grant CEPI has ever made.</p><p>Novavax got an even bigger check from the U.S. government when Operation Warp Speed (OWS) pre-ordered 100 million doses of the company's COVID-19 vaccine and paid $1.6 billion in advance. Multiple governments around the world followed suit. So far, Novavax has received orders for 2 billion doses of its COVID-19 vaccine. Management estimates it will make over $4 billion in revenue in 2022 and maybe as much as $5 billion.</p><h2>Green Flag #2: The stock is cheap, and the opportunity massive</h2><p>At the end of Q1, Novavax reported $1.6 billion in cash. So right now, the stock is trading at less than three times cash. Its forward price-to-earnings (P/E) ratio is 1.6, and its price-to-sales (P/S) ratio is 1.8. This is incredibly cheap given how fast revenue is escalating. In Q1, the biotech delivered 42 million doses of the COVID vaccine to the European Union (EU), Canada, South Korea, Australia, New Zealand, and Indonesia.</p><p>While 42 million is a lot, Novavax's massive roll-out has just begun. The company anticipates an Emergency Use Authorization (EUA) from American regulators this month. A few weeks ago, the FDA's advisory committee voted 21-0 that Novavax's vaccine should be available to the people of the United States. If and when the FDA follows the advice of its advisory committee, Novavax will be allowed to start shipping 110 million doses of vaccine in the U.S.</p><p>While the stock market is waiting for the FDA's decision, most of Novavax's market opportunity is actually abroad. The company has already received authorizations to ship its vaccines to over 170 countries. This is huge for Novavax as the biotech has advance-purchase agreements for up to 430 million doses, or 10 times what it delivered in Q1.</p><h2>Green Flag #3: At least $7 billion in near-term revenue</h2><p>If 42 million doses brought in $700 million in Q1, what will 430 million doses bring in? And note that these contracts are in many of the same places that were responsible for the Q1 revenue (EU, Canada, Australia, and New Zealand).</p><p>While Novavax keeps its pricing data secret, these deals were made when the pandemic was at its worst. If the price points are similar, the company might pull in $7 billion from these contracts alone (some of this revenue will likely spill over into 2023). So management's estimate of $4 billion to $5 billion in revenues for 2022 seems very doable.</p><p>What's remarkable is that this $7 billion does not include <i>any</i> revenue from the 110 million doses in the U.S.; nor does it include the 1.1 billion doses that Novavax is distributing to COVID-19 Vaccines Global Access (COVAX) as part of its CEPI obligations, nor another 400 million doses the company is distributing as part of licensing agreements in Asia. So to my mind, this back-of-the-envelope $7 billion calculation is a floor -- not a ceiling.</p><h2>Red Flag: Can Novavax deliver 2 billion doses?</h2><p>The big question for Novavax is not in regard to its science -- some observers call its vaccine best-in-class -- but rather the manufacturing issues which have dogged the tiny biotech. Novavax has signed multiple contracts with third-party sites to manufacture its COVID vaccine. So far, however, the only site that has been approved by regulators is the Serum Institute of India (the largest vaccine manufacturer in the world by volume). Some of the other manufacturing sites have been hampered by purity issues.</p><p>It's these manufacturing difficulties that have caused a year-long delay in getting this vaccine to market in the U.S. Novavax's share price hit $330 in the days after the company released its amazing phase 3 data for its COVID vaccine in early 2021. But after all the delays, the stock has seen a massive price drop to $50 a share, while <b>Pfizer </b>and <b>Moderna</b> have vaccinated most of the country.</p><p>Nonetheless, I'm very bullish that Novavax will solve its manufacturing issues. The Serum Institute can and will produce a billion doses of the vaccine. (That's the manufacturer Novavax has relied on to get its EUAs around the world). And now additional manufacturing sites are approaching readiness. In April, the biotech submitted data from another highly regarded manufacturer, SK Bioscience, to European health authorities. And in Q2, Novavax will file data from its own manufacturing site in the Czech Republic. That state-of-the-art facility will ultimately manufacture another one billion doses a year for Novavax.</p><h2>What is the future for Novavax?</h2><p>The market, with its short-term dynamics, seems to think that COVID-19 is over. While I wish this were the case, I'm afraid it's highly unlikely. Since COVID mutates like flu viruses, many of us may well need to be vaccinated annually. COVID hospitalizations spiked dramatically in the winters of 2020 and 2021, so that is likely to happen this year too. Like the flu, the worst cases of COVID seem to be seasonal.</p><p>In that regard, Novavax is in the lead in finding a flu/COVID combo vaccine. The company has already started clinical trials and will advance its candidate into a phase 2 trial later this year. Over the next year or two, I expect Novavax revenue to spike a lot higher. But the real gains will happen if and when Novavax is first to market with its COVID/flu combo shot.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Reasons to Buy Novavax and 1 to Sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Reasons to Buy Novavax and 1 to Sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-28 10:16 GMT+8 <a href=https://www.fool.com/investing/2022/06/27/3-reasons-to-buy-novavax-and-1-to-sell/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax is a pandemic stock. That's why it soared in 2020-21 when the world faced the worst pandemic since the influenza outbreak of 1918. When COVID-19 hit, this vaccine biotech made an almost ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/06/27/3-reasons-to-buy-novavax-and-1-to-sell/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2022/06/27/3-reasons-to-buy-novavax-and-1-to-sell/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2246803790","content_text":"Novavax is a pandemic stock. That's why it soared in 2020-21 when the world faced the worst pandemic since the influenza outbreak of 1918. When COVID-19 hit, this vaccine biotech made an almost impossible run, from a low of $4 a share all the way to $330.Now it's down to $50, and the company's market cap is under $4 billion. Is it a buy at these prices? Here are three arguments for buying Novavax stock and one reason for why you might want to avoid these shares.Image source: Getty Images.Green Flag #1: Huge revenue in 2022 plus profits!In the first quarter, Novavax reported its first profitable quarter as a public company, with $200 million in profits off of $700 million in sales. That's a huge step up for a biotech, which has been unprofitable since it hit the public markets way back in the 20th century (1995 to be exact).Novavax is a scrappy underdog that has survived for almost three decades without making any money. When Stan Erck arrived at the CEO slot in 2011, the company turned its focus toward vaccines to thwart pandemics. So if you're worried about severe acute respiratory syndrome (SARS), Novavax has discovered a potential vaccine for that. The biotech also has vaccine candidates in its pipeline for Ebola, malaria, Middle East respiratory syndrome (MERS), and influenza.None of those drugs have been approved yet (Novavax is still waiting for its first FDA approval), but all of this scientific research gave the small biotech a big advantage when it came to combating the new coronavirus that hit the world two years ago. Based on its research, Novavax was awarded a massive $399 million check from the Bill Gates-funded Coalition for Epidemic Preparedness Innovations (CEPI). It's still the largest grant CEPI has ever made.Novavax got an even bigger check from the U.S. government when Operation Warp Speed (OWS) pre-ordered 100 million doses of the company's COVID-19 vaccine and paid $1.6 billion in advance. Multiple governments around the world followed suit. So far, Novavax has received orders for 2 billion doses of its COVID-19 vaccine. Management estimates it will make over $4 billion in revenue in 2022 and maybe as much as $5 billion.Green Flag #2: The stock is cheap, and the opportunity massiveAt the end of Q1, Novavax reported $1.6 billion in cash. So right now, the stock is trading at less than three times cash. Its forward price-to-earnings (P/E) ratio is 1.6, and its price-to-sales (P/S) ratio is 1.8. This is incredibly cheap given how fast revenue is escalating. In Q1, the biotech delivered 42 million doses of the COVID vaccine to the European Union (EU), Canada, South Korea, Australia, New Zealand, and Indonesia.While 42 million is a lot, Novavax's massive roll-out has just begun. The company anticipates an Emergency Use Authorization (EUA) from American regulators this month. A few weeks ago, the FDA's advisory committee voted 21-0 that Novavax's vaccine should be available to the people of the United States. If and when the FDA follows the advice of its advisory committee, Novavax will be allowed to start shipping 110 million doses of vaccine in the U.S.While the stock market is waiting for the FDA's decision, most of Novavax's market opportunity is actually abroad. The company has already received authorizations to ship its vaccines to over 170 countries. This is huge for Novavax as the biotech has advance-purchase agreements for up to 430 million doses, or 10 times what it delivered in Q1.Green Flag #3: At least $7 billion in near-term revenueIf 42 million doses brought in $700 million in Q1, what will 430 million doses bring in? And note that these contracts are in many of the same places that were responsible for the Q1 revenue (EU, Canada, Australia, and New Zealand).While Novavax keeps its pricing data secret, these deals were made when the pandemic was at its worst. If the price points are similar, the company might pull in $7 billion from these contracts alone (some of this revenue will likely spill over into 2023). So management's estimate of $4 billion to $5 billion in revenues for 2022 seems very doable.What's remarkable is that this $7 billion does not include any revenue from the 110 million doses in the U.S.; nor does it include the 1.1 billion doses that Novavax is distributing to COVID-19 Vaccines Global Access (COVAX) as part of its CEPI obligations, nor another 400 million doses the company is distributing as part of licensing agreements in Asia. So to my mind, this back-of-the-envelope $7 billion calculation is a floor -- not a ceiling.Red Flag: Can Novavax deliver 2 billion doses?The big question for Novavax is not in regard to its science -- some observers call its vaccine best-in-class -- but rather the manufacturing issues which have dogged the tiny biotech. Novavax has signed multiple contracts with third-party sites to manufacture its COVID vaccine. So far, however, the only site that has been approved by regulators is the Serum Institute of India (the largest vaccine manufacturer in the world by volume). Some of the other manufacturing sites have been hampered by purity issues.It's these manufacturing difficulties that have caused a year-long delay in getting this vaccine to market in the U.S. Novavax's share price hit $330 in the days after the company released its amazing phase 3 data for its COVID vaccine in early 2021. But after all the delays, the stock has seen a massive price drop to $50 a share, while Pfizer and Moderna have vaccinated most of the country.Nonetheless, I'm very bullish that Novavax will solve its manufacturing issues. The Serum Institute can and will produce a billion doses of the vaccine. (That's the manufacturer Novavax has relied on to get its EUAs around the world). And now additional manufacturing sites are approaching readiness. In April, the biotech submitted data from another highly regarded manufacturer, SK Bioscience, to European health authorities. And in Q2, Novavax will file data from its own manufacturing site in the Czech Republic. That state-of-the-art facility will ultimately manufacture another one billion doses a year for Novavax.What is the future for Novavax?The market, with its short-term dynamics, seems to think that COVID-19 is over. While I wish this were the case, I'm afraid it's highly unlikely. Since COVID mutates like flu viruses, many of us may well need to be vaccinated annually. COVID hospitalizations spiked dramatically in the winters of 2020 and 2021, so that is likely to happen this year too. Like the flu, the worst cases of COVID seem to be seasonal.In that regard, Novavax is in the lead in finding a flu/COVID combo vaccine. The company has already started clinical trials and will advance its candidate into a phase 2 trial later this year. Over the next year or two, I expect Novavax revenue to spike a lot higher. But the real gains will happen if and when Novavax is first to market with its COVID/flu combo shot.","news_type":1},"isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064149897,"gmtCreate":1652308475419,"gmtModify":1676535071619,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] ","listText":"[Call] [Call] [Call] ","text":"[Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064149897","repostId":"2234987948","repostType":4,"repost":{"id":"2234987948","kind":"highlight","pubTimestamp":1652276916,"share":"https://ttm.financial/m/news/2234987948?lang=&edition=fundamental","pubTime":"2022-05-11 21:48","market":"us","language":"en","title":"3 Beaten-Down Growth Stocks Worth Buying on the Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2234987948","media":"Motley Fool","summary":"These companies are posting growth where it counts and trade at fair valuations.","content":"<html><head></head><body><p>So far, the <b>Nasdaq Composite</b> is the only major index to officially enter a bear market. The Nasdaq is down about 28% from its all-time high, but with many high-profile companies down even more, this market downturn feels much more severe.</p><p>It's comforting to remember that stocks are not lottery tickets. If you buy a stock, you own a piece of a business. And if that business is growing revenue and profits, the stock is going to go up at some point. That's why all bear markets have been followed by longer periods of rising stock prices.</p><p>Three widely followed companies just reported better-than-expected revenue results. After falling significantly year-to-date, these stocks could be great buys.</p><p>1. <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a></p><p>In <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>'s fiscal third quarter (which ended March 31), revenue grew 18% year over year, with adjusted earnings up 14%. Both numbers beat the Wall Street consensus.</p><p>Management credited strong demand for cloud services and better-than-expected commercial bookings growth of 28% for the strong results last quarter. Indeed, Microsoft Azure continues to look strong for the software giant. Azure and other cloud services grew 46% year over year, which is notably faster than <b>Amazon</b>, which reported cloud growth of 37% last quarter.</p><p>Microsoft is performing very strong in all segments. LinkedIn's revenue growth accelerated from 25% in the year-ago quarter to 34%, and Office consumer products and services also accelerated from a 5% rate in the year-ago quarter to 11% this year.</p><p>The stock is down 20% year-to-date. Microsoft's valuation at the beginning of the year might have been on the high side, but at a current price-to-earnings ratio of 28, it is looking more attractive. With the company posting double-digit revenue and earnings growth, the stock appears fairly valued at these levels and should deliver good returns over the long term.</p><p><img src=\"https://static.tigerbbs.com/1709f3bf6d7d406580544548f5b6a751\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><p>2. <a href=\"https://laohu8.com/S/AMD\">Advanced Micro Devices</a></p><p><a href=\"https://laohu8.com/S/AMD\">Advanced Micro Devices</a> has delivered staggering returns over the last few years as it's taken market share away from <b>Intel</b>'s dominant position. While AMD has been behind the lead of <b>Nvidia</b> in the graphics processing unit (GPU) market, a rising tide in the semiconductor industry has lifted all boats.</p><p>AMD reported results that blasted away Wall Street estimates in the first quarter. Revenue of $5.9 billion beat analyst estimates of $5.01 billion, while adjusted earnings per share of $1.13 demolished estimates of $0.91.</p><p>Excluding the acquisition of Xilinx, AMD's adjusted revenue was $5.3 billion, representing an increase of 51% year over year. Strong demand for GPUs drove a 33% increase in the computing and graphics segment. But the most impressive performance was from the enterprise, embedded, and semi-custom business, with revenue up 88% over the year-ago quarter.</p><p>AMD reported record EPYC processor sales used in servers and strong demand for <b>Sony</b> and Microsoft's video game consoles, which are powered by custom AMD processors. For the third consecutive quarter, EPYC processor sales more than doubled, reflecting strong demand from cloud service providers that use high-performance chips to process large data workloads.</p><p>AMD raised full-year guidance and now expects revenue to grow about 60% over 2021. Investors are currently paying only 20 times 2022 earnings estimates for shares, which is incredibly cheap for such a fast-growing business. The addition of Xilinx will extend AMD's growth opportunity to connected devices and other data-intensive workloads. The company estimates the opportunity at $135 billion.</p><p><img src=\"https://static.tigerbbs.com/4a8e2e92c4e643868fc6c9f530f66286\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><p>3. <a href=\"https://laohu8.com/S/ABNB\">Airbnb</a></p><p><a href=\"https://laohu8.com/S/ABNB\">Airbnb</a> is enjoying tremendous growth after the pandemic slowed travel worldwide. In the first quarter, revenue jumped 70% year over year to $1.5 billion, beating analyst estimates of $1.45 billion. While Airbnb reported a net loss of $19 million, it was enough to slightly surpass expectations.</p><p>The strong start to 2022 continues a string of outstanding quarters over the last year. Airbnb continues to see people visiting non-urban areas close to home, with long-term stays remaining the fastest-growing category. The company also says that people are booking travel destinations further in advance, with lead times surpassing 2019 levels at the end of the first quarter.</p><p>It's encouraging that Airbnb is experiencing this much pent-up demand even with economic headwinds, such as higher gas prices. Overall, nights and experiences booked on the platform surpassed pre-pandemic levels and crossed the 100 million mark for the first time in the company's 15-year history.</p><p>Most importantly, Airbnb's growth is starting to light a fire under profitability -- a good reason to consider buying the stock. Over the last four quarters, free cash flow totaled $2.9 billion. That puts Airbnb's market cap at just 27 times trailing free cash flow, which is too low for a top travel service that is experiencing this much momentum.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Growth Stocks Worth Buying on the Dip</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Growth Stocks Worth Buying on the Dip\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-11 21:48 GMT+8 <a href=https://www.fool.com/investing/2022/05/11/3-beaten-down-growth-stocks-worth-buying/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>So far, the Nasdaq Composite is the only major index to officially enter a bear market. The Nasdaq is down about 28% from its all-time high, but with many high-profile companies down even more, this ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/11/3-beaten-down-growth-stocks-worth-buying/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4548":"巴美列捷福持仓","BK4529":"IDC概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4576":"AR","BK4525":"远程办公概念","BK4575":"芯片概念","BK4566":"资本集团","INTC":"英特尔","BK4535":"淡马锡持仓","AMD":"美国超微公司","BK4527":"明星科技股","BK4538":"云计算","BK4577":"网络游戏","MSFT":"微软","BK4550":"红杉资本持仓","BK4579":"人工智能","BK4141":"半导体产品","BK4503":"景林资产持仓","ABNB":"爱彼迎","BK4097":"系统软件","BK4573":"虚拟现实","BK4561":"索罗斯持仓","GFS":"GLOBALFOUNDRIES Inc.","BK4505":"高瓴资本持仓","BK4581":"高盛持仓","BK4504":"桥水持仓","BK4512":"苹果概念","BK4142":"酒店、度假村与豪华游轮"},"source_url":"https://www.fool.com/investing/2022/05/11/3-beaten-down-growth-stocks-worth-buying/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2234987948","content_text":"So far, the Nasdaq Composite is the only major index to officially enter a bear market. The Nasdaq is down about 28% from its all-time high, but with many high-profile companies down even more, this market downturn feels much more severe.It's comforting to remember that stocks are not lottery tickets. If you buy a stock, you own a piece of a business. And if that business is growing revenue and profits, the stock is going to go up at some point. That's why all bear markets have been followed by longer periods of rising stock prices.Three widely followed companies just reported better-than-expected revenue results. After falling significantly year-to-date, these stocks could be great buys.1. MicrosoftIn Microsoft's fiscal third quarter (which ended March 31), revenue grew 18% year over year, with adjusted earnings up 14%. Both numbers beat the Wall Street consensus.Management credited strong demand for cloud services and better-than-expected commercial bookings growth of 28% for the strong results last quarter. Indeed, Microsoft Azure continues to look strong for the software giant. Azure and other cloud services grew 46% year over year, which is notably faster than Amazon, which reported cloud growth of 37% last quarter.Microsoft is performing very strong in all segments. LinkedIn's revenue growth accelerated from 25% in the year-ago quarter to 34%, and Office consumer products and services also accelerated from a 5% rate in the year-ago quarter to 11% this year.The stock is down 20% year-to-date. Microsoft's valuation at the beginning of the year might have been on the high side, but at a current price-to-earnings ratio of 28, it is looking more attractive. With the company posting double-digit revenue and earnings growth, the stock appears fairly valued at these levels and should deliver good returns over the long term.Image source: Getty Images.2. Advanced Micro DevicesAdvanced Micro Devices has delivered staggering returns over the last few years as it's taken market share away from Intel's dominant position. While AMD has been behind the lead of Nvidia in the graphics processing unit (GPU) market, a rising tide in the semiconductor industry has lifted all boats.AMD reported results that blasted away Wall Street estimates in the first quarter. Revenue of $5.9 billion beat analyst estimates of $5.01 billion, while adjusted earnings per share of $1.13 demolished estimates of $0.91.Excluding the acquisition of Xilinx, AMD's adjusted revenue was $5.3 billion, representing an increase of 51% year over year. Strong demand for GPUs drove a 33% increase in the computing and graphics segment. But the most impressive performance was from the enterprise, embedded, and semi-custom business, with revenue up 88% over the year-ago quarter.AMD reported record EPYC processor sales used in servers and strong demand for Sony and Microsoft's video game consoles, which are powered by custom AMD processors. For the third consecutive quarter, EPYC processor sales more than doubled, reflecting strong demand from cloud service providers that use high-performance chips to process large data workloads.AMD raised full-year guidance and now expects revenue to grow about 60% over 2021. Investors are currently paying only 20 times 2022 earnings estimates for shares, which is incredibly cheap for such a fast-growing business. The addition of Xilinx will extend AMD's growth opportunity to connected devices and other data-intensive workloads. The company estimates the opportunity at $135 billion.Image source: Getty Images.3. AirbnbAirbnb is enjoying tremendous growth after the pandemic slowed travel worldwide. In the first quarter, revenue jumped 70% year over year to $1.5 billion, beating analyst estimates of $1.45 billion. While Airbnb reported a net loss of $19 million, it was enough to slightly surpass expectations.The strong start to 2022 continues a string of outstanding quarters over the last year. Airbnb continues to see people visiting non-urban areas close to home, with long-term stays remaining the fastest-growing category. The company also says that people are booking travel destinations further in advance, with lead times surpassing 2019 levels at the end of the first quarter.It's encouraging that Airbnb is experiencing this much pent-up demand even with economic headwinds, such as higher gas prices. Overall, nights and experiences booked on the platform surpassed pre-pandemic levels and crossed the 100 million mark for the first time in the company's 15-year history.Most importantly, Airbnb's growth is starting to light a fire under profitability -- a good reason to consider buying the stock. Over the last four quarters, free cash flow totaled $2.9 billion. That puts Airbnb's market cap at just 27 times trailing free cash flow, which is too low for a top travel service that is experiencing this much momentum.","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9065078114,"gmtCreate":1652137137938,"gmtModify":1676535035142,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Cry] [Cry] [Cry] ","listText":"[Cry] [Cry] [Cry] ","text":"[Cry] [Cry] [Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9065078114","repostId":"2234504689","repostType":2,"repost":{"id":"2234504689","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1652136651,"share":"https://ttm.financial/m/news/2234504689?lang=&edition=fundamental","pubTime":"2022-05-10 06:50","market":"us","language":"en","title":"Novavax Posts First Quarterly Profit, but Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2234504689","media":"Dow Jones","summary":"Vaccine maker keeps 2022 revenue guidance intactShares of Novavax Inc. dropped more than 18% in the ","content":"<html><head></head><body><p>Vaccine maker keeps 2022 revenue guidance intact</p><p>Shares of Novavax Inc. dropped more than 18% in the extended session Monday after the biotech company reported its first profitable quarter, but not by as much as Wall Street expected, and its sales were also below estimates.</p><p><img src=\"https://static.tigerbbs.com/ee81b2f2acc1426f7fd21faf826b0233\" tg-width=\"840\" tg-height=\"618\" referrerpolicy=\"no-referrer\"/></p><p>Novavax said it earned $203 million, or $2.56 a share, in the quarter, swinging from a net loss of $223 million, or $3.05 a share, in the year-ago period.</p><p>Revenue rose to $704 million, from $447 million a year ago.</p><p>Analysts polled by FactSet expected Novavax to report earnings of $2.69 a share on sales of $845 million.</p><p>Novavax said it has been "successful" in launching its COVID-19 vaccine worldwide and it is on track to expand its label use.</p><p>"Importantly, as new variants have emerged, we have progressed our strategy to be ready to address the dynamic environment and continue development beyond COVID-19 with our COVID-19-influenza combination vaccine candidate," Chief Executive Stanley C. Erck said in a statement.</p><p>Novavax also reiterated its 2022 revenue guidance of between $4 billion and $5 billion.</p><p>The company has submitted a emergency-use authorization request for its COVID-19 vaccine, with the U.S. Food and Drug Administration's advisory committee scheduled to meet June 7. The vaccine is authorized in a few other countries.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Posts First Quarterly Profit, but Misses Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Posts First Quarterly Profit, but Misses Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-05-10 06:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Vaccine maker keeps 2022 revenue guidance intact</p><p>Shares of Novavax Inc. dropped more than 18% in the extended session Monday after the biotech company reported its first profitable quarter, but not by as much as Wall Street expected, and its sales were also below estimates.</p><p><img src=\"https://static.tigerbbs.com/ee81b2f2acc1426f7fd21faf826b0233\" tg-width=\"840\" tg-height=\"618\" referrerpolicy=\"no-referrer\"/></p><p>Novavax said it earned $203 million, or $2.56 a share, in the quarter, swinging from a net loss of $223 million, or $3.05 a share, in the year-ago period.</p><p>Revenue rose to $704 million, from $447 million a year ago.</p><p>Analysts polled by FactSet expected Novavax to report earnings of $2.69 a share on sales of $845 million.</p><p>Novavax said it has been "successful" in launching its COVID-19 vaccine worldwide and it is on track to expand its label use.</p><p>"Importantly, as new variants have emerged, we have progressed our strategy to be ready to address the dynamic environment and continue development beyond COVID-19 with our COVID-19-influenza combination vaccine candidate," Chief Executive Stanley C. Erck said in a statement.</p><p>Novavax also reiterated its 2022 revenue guidance of between $4 billion and $5 billion.</p><p>The company has submitted a emergency-use authorization request for its COVID-19 vaccine, with the U.S. Food and Drug Administration's advisory committee scheduled to meet June 7. The vaccine is authorized in a few other countries.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2234504689","content_text":"Vaccine maker keeps 2022 revenue guidance intactShares of Novavax Inc. dropped more than 18% in the extended session Monday after the biotech company reported its first profitable quarter, but not by as much as Wall Street expected, and its sales were also below estimates.Novavax said it earned $203 million, or $2.56 a share, in the quarter, swinging from a net loss of $223 million, or $3.05 a share, in the year-ago period.Revenue rose to $704 million, from $447 million a year ago.Analysts polled by FactSet expected Novavax to report earnings of $2.69 a share on sales of $845 million.Novavax said it has been \"successful\" in launching its COVID-19 vaccine worldwide and it is on track to expand its label use.\"Importantly, as new variants have emerged, we have progressed our strategy to be ready to address the dynamic environment and continue development beyond COVID-19 with our COVID-19-influenza combination vaccine candidate,\" Chief Executive Stanley C. Erck said in a statement.Novavax also reiterated its 2022 revenue guidance of between $4 billion and $5 billion.The company has submitted a emergency-use authorization request for its COVID-19 vaccine, with the U.S. Food and Drug Administration's advisory committee scheduled to meet June 7. The vaccine is authorized in a few other countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":93,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9026072788,"gmtCreate":1653307929444,"gmtModify":1676535257146,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026072788","repostId":"1163224981","repostType":4,"repost":{"id":"1163224981","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1653307076,"share":"https://ttm.financial/m/news/1163224981?lang=&edition=fundamental","pubTime":"2022-05-23 19:57","market":"us","language":"en","title":"Pre-Bell|U.S. Stock Futures Rebound; Takeover Talks Boost VMware","url":"https://stock-news.laohu8.com/highlight/detail?id=1163224981","media":"Tiger Newspress","summary":"Wall Street futures rose on Monday, helped by a bounce in growth stocks and banks, after the benchma","content":"<html><head></head><body><p>Wall Street futures rose on Monday, helped by a bounce in growth stocks and banks, after the benchmark S&P 500 hovered near a grim market milestone at the end of last week.</p><p>Investors will keep a close eye on the slew of economic data expected this week that could shed new light on the health of U.S. economy against the backdrop of a steep selloff in stocks since January.</p><p><b>Market Snapshot</b></p><p>At 07:45 a.m. ET, Dow e-minis were up 304 points, or 0.97%, S&P 500 e-minis were up 39.75 points, or 1.02%, and Nasdaq 100 e-minis were up 96.75 points, or 0.82%.</p><p><img src=\"https://static.tigerbbs.com/1fd39d5dd2eb69502af0a0c70483fa3f\" tg-width=\"383\" tg-height=\"185\" referrerpolicy=\"no-referrer\"/></p><p><b>Pre-Market Movers</b></p><p><b>Electronic Arts (EA)</b> – The video game maker’s shares rose 3.3% in the premarket after Puck News reported that the company was actively seeking a buyer or merger partner. EA has reportedly held talks with Walt Disney (DIS), Apple (AAPL) and Amazon (AMZN), among others.</p><p><b>Xpeng (XPEV)</b> – Chinese electric-vehicle maker Xpeng Inc. reported a wider-than-expected quarterly loss as supply-chain snarls and surging materials costs squeeze margins. Xpeng shares trimmed their losses to 0.4% from 4% in premarket trading.</p><p><b>VMWare (VMW)</b> – The cloud computing company’s stock surged 22.7% in premarket trading following multiple reports that it is in advanced talks to be bought by chipmaker <b>Broadcom (AVGO)</b>. The two companies are said to be discussing a cash-and-stock deal which could happen soon, according to people familiar with the matter. Broadcom slid 4.7%.</p><p><b>GameStop (GME)</b> – GameStop jumped 2.2% in premarket trading after the video game retailer launched a digital wallet for cryptocurrencies and NFTs.</p><p><b>HP Inc. (HPQ)</b> – The computer and printer maker was downgraded to “neutral” from “buy” at Citi, based on moderating demand for PCs in the near to mid-term. HP fell 2.9% in premarket action.</p><p><b>Pfizer (PFE)</b> – Pfizer and partner <b>BioNTech (BNTX)</b> said three doses of their Covid-19 vaccine offered strong protection for children under 5, according to preliminary data. BioNTech rose 1.9% in premarket trading, while Pfizer edged higher by 0.6%.</p><p><b>Motorola Solutions (MSI)</b> – Morgan Stanley upgraded the communications equipment and software company’s stock to “overweight” from “equal-weight,” with a number of favorable trends in place including an increase in demand for video surveillance. Motorola Solutions gained 2.5% in the premarket.</p><p><b>Emergent BioSolutions (EBS)</b> – The biopharma company’s stock rallied 9.7% in premarket trading, amid the increasing concerns about the spread of monkeypox. Emergent is a supplier of smallpox vaccine, which can be used as protection against monkeypox.</p><p><b>Autodesk (ADSK)</b> – The design software company’s stock fell 3.7% in premarket action after RBC cut its price target on the stock to $255 per share from $295 a share. RBC said Street earnings consensus may be too high and that Autodesk needs to establish consistency in its results to increase investor confidence.</p><p><b>Boeing (BA)</b> – Boeing rose 1% in premarket trading after its Starliner spacecraft successfully docked with the International Space Station over the weekend.</p><p><b>Corning (GLW)</b> – The materials science company’s stock slid 2.9% in the premarket after Citi downgraded it to “neutral” from “buy,” citing lower PC and tablet demand impacting Corning’s optical components business. Citi also notes uncertainty about demand recovery for premium and large-size televisions.</p><p><b>Market News</b></p><p><b>Biden Says Weighs Reducing Tariffs on China, Asking OPEC to Pump More Oil</b></p><p>U.S. President Joe Biden said he was weighing cutting tariffs on Chinese goods while increasing calls on OPEC to raise oil production as he grappled with a politically damaging wave of inflation.</p><p>"I am considering it. We did not impose any of those tariffs. They were imposed by the last administration and they're under consideration," Biden said on reducing tariffs on China.</p><p><b>Broadcom in Advanced Talks to Buy VMware</b></p><p>Broadcom Inc. is in advanced talks to buy VMware Inc., according to people familiar with the matter, setting the stage for what would be one of the year’s biggest deals.</p><p>The technology companies are discussing a cash-and-stock deal that could come soon, assuming the talks don’t fall apart, the people said. VMware has a market value of $40 billion, while Broadcom’s is around $222 billion.</p><p>The deal discussions, which picked up pace in recent days, come roughly six months after computing pioneer Dell Technologies Inc. spun off its 81% equity stake in VMware.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pre-Bell|U.S. Stock Futures Rebound; Takeover Talks Boost VMware</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPre-Bell|U.S. Stock Futures Rebound; Takeover Talks Boost VMware\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-23 19:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Wall Street futures rose on Monday, helped by a bounce in growth stocks and banks, after the benchmark S&P 500 hovered near a grim market milestone at the end of last week.</p><p>Investors will keep a close eye on the slew of economic data expected this week that could shed new light on the health of U.S. economy against the backdrop of a steep selloff in stocks since January.</p><p><b>Market Snapshot</b></p><p>At 07:45 a.m. ET, Dow e-minis were up 304 points, or 0.97%, S&P 500 e-minis were up 39.75 points, or 1.02%, and Nasdaq 100 e-minis were up 96.75 points, or 0.82%.</p><p><img src=\"https://static.tigerbbs.com/1fd39d5dd2eb69502af0a0c70483fa3f\" tg-width=\"383\" tg-height=\"185\" referrerpolicy=\"no-referrer\"/></p><p><b>Pre-Market Movers</b></p><p><b>Electronic Arts (EA)</b> – The video game maker’s shares rose 3.3% in the premarket after Puck News reported that the company was actively seeking a buyer or merger partner. EA has reportedly held talks with Walt Disney (DIS), Apple (AAPL) and Amazon (AMZN), among others.</p><p><b>Xpeng (XPEV)</b> – Chinese electric-vehicle maker Xpeng Inc. reported a wider-than-expected quarterly loss as supply-chain snarls and surging materials costs squeeze margins. Xpeng shares trimmed their losses to 0.4% from 4% in premarket trading.</p><p><b>VMWare (VMW)</b> – The cloud computing company’s stock surged 22.7% in premarket trading following multiple reports that it is in advanced talks to be bought by chipmaker <b>Broadcom (AVGO)</b>. The two companies are said to be discussing a cash-and-stock deal which could happen soon, according to people familiar with the matter. Broadcom slid 4.7%.</p><p><b>GameStop (GME)</b> – GameStop jumped 2.2% in premarket trading after the video game retailer launched a digital wallet for cryptocurrencies and NFTs.</p><p><b>HP Inc. (HPQ)</b> – The computer and printer maker was downgraded to “neutral” from “buy” at Citi, based on moderating demand for PCs in the near to mid-term. HP fell 2.9% in premarket action.</p><p><b>Pfizer (PFE)</b> – Pfizer and partner <b>BioNTech (BNTX)</b> said three doses of their Covid-19 vaccine offered strong protection for children under 5, according to preliminary data. BioNTech rose 1.9% in premarket trading, while Pfizer edged higher by 0.6%.</p><p><b>Motorola Solutions (MSI)</b> – Morgan Stanley upgraded the communications equipment and software company’s stock to “overweight” from “equal-weight,” with a number of favorable trends in place including an increase in demand for video surveillance. Motorola Solutions gained 2.5% in the premarket.</p><p><b>Emergent BioSolutions (EBS)</b> – The biopharma company’s stock rallied 9.7% in premarket trading, amid the increasing concerns about the spread of monkeypox. Emergent is a supplier of smallpox vaccine, which can be used as protection against monkeypox.</p><p><b>Autodesk (ADSK)</b> – The design software company’s stock fell 3.7% in premarket action after RBC cut its price target on the stock to $255 per share from $295 a share. RBC said Street earnings consensus may be too high and that Autodesk needs to establish consistency in its results to increase investor confidence.</p><p><b>Boeing (BA)</b> – Boeing rose 1% in premarket trading after its Starliner spacecraft successfully docked with the International Space Station over the weekend.</p><p><b>Corning (GLW)</b> – The materials science company’s stock slid 2.9% in the premarket after Citi downgraded it to “neutral” from “buy,” citing lower PC and tablet demand impacting Corning’s optical components business. Citi also notes uncertainty about demand recovery for premium and large-size televisions.</p><p><b>Market News</b></p><p><b>Biden Says Weighs Reducing Tariffs on China, Asking OPEC to Pump More Oil</b></p><p>U.S. President Joe Biden said he was weighing cutting tariffs on Chinese goods while increasing calls on OPEC to raise oil production as he grappled with a politically damaging wave of inflation.</p><p>"I am considering it. We did not impose any of those tariffs. They were imposed by the last administration and they're under consideration," Biden said on reducing tariffs on China.</p><p><b>Broadcom in Advanced Talks to Buy VMware</b></p><p>Broadcom Inc. is in advanced talks to buy VMware Inc., according to people familiar with the matter, setting the stage for what would be one of the year’s biggest deals.</p><p>The technology companies are discussing a cash-and-stock deal that could come soon, assuming the talks don’t fall apart, the people said. VMware has a market value of $40 billion, while Broadcom’s is around $222 billion.</p><p>The deal discussions, which picked up pace in recent days, come roughly six months after computing pioneer Dell Technologies Inc. spun off its 81% equity stake in VMware.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EBS":"Emergent Biosolutions","VMW":"威睿","MSI":"摩托罗拉解决方案","GME":"游戏驿站","ADSK":"欧特克","EA":"艺电","PFE":"辉瑞","XPEV":"小鹏汽车",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BA":"波音",".SPX":"S&P 500 Index","AVGO":"博通","GLW":"康宁","BNTX":"BioNTech SE","HPQ":"惠普"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163224981","content_text":"Wall Street futures rose on Monday, helped by a bounce in growth stocks and banks, after the benchmark S&P 500 hovered near a grim market milestone at the end of last week.Investors will keep a close eye on the slew of economic data expected this week that could shed new light on the health of U.S. economy against the backdrop of a steep selloff in stocks since January.Market SnapshotAt 07:45 a.m. ET, Dow e-minis were up 304 points, or 0.97%, S&P 500 e-minis were up 39.75 points, or 1.02%, and Nasdaq 100 e-minis were up 96.75 points, or 0.82%.Pre-Market MoversElectronic Arts (EA) – The video game maker’s shares rose 3.3% in the premarket after Puck News reported that the company was actively seeking a buyer or merger partner. EA has reportedly held talks with Walt Disney (DIS), Apple (AAPL) and Amazon (AMZN), among others.Xpeng (XPEV) – Chinese electric-vehicle maker Xpeng Inc. reported a wider-than-expected quarterly loss as supply-chain snarls and surging materials costs squeeze margins. Xpeng shares trimmed their losses to 0.4% from 4% in premarket trading.VMWare (VMW) – The cloud computing company’s stock surged 22.7% in premarket trading following multiple reports that it is in advanced talks to be bought by chipmaker Broadcom (AVGO). The two companies are said to be discussing a cash-and-stock deal which could happen soon, according to people familiar with the matter. Broadcom slid 4.7%.GameStop (GME) – GameStop jumped 2.2% in premarket trading after the video game retailer launched a digital wallet for cryptocurrencies and NFTs.HP Inc. (HPQ) – The computer and printer maker was downgraded to “neutral” from “buy” at Citi, based on moderating demand for PCs in the near to mid-term. HP fell 2.9% in premarket action.Pfizer (PFE) – Pfizer and partner BioNTech (BNTX) said three doses of their Covid-19 vaccine offered strong protection for children under 5, according to preliminary data. BioNTech rose 1.9% in premarket trading, while Pfizer edged higher by 0.6%.Motorola Solutions (MSI) – Morgan Stanley upgraded the communications equipment and software company’s stock to “overweight” from “equal-weight,” with a number of favorable trends in place including an increase in demand for video surveillance. Motorola Solutions gained 2.5% in the premarket.Emergent BioSolutions (EBS) – The biopharma company’s stock rallied 9.7% in premarket trading, amid the increasing concerns about the spread of monkeypox. Emergent is a supplier of smallpox vaccine, which can be used as protection against monkeypox.Autodesk (ADSK) – The design software company’s stock fell 3.7% in premarket action after RBC cut its price target on the stock to $255 per share from $295 a share. RBC said Street earnings consensus may be too high and that Autodesk needs to establish consistency in its results to increase investor confidence.Boeing (BA) – Boeing rose 1% in premarket trading after its Starliner spacecraft successfully docked with the International Space Station over the weekend.Corning (GLW) – The materials science company’s stock slid 2.9% in the premarket after Citi downgraded it to “neutral” from “buy,” citing lower PC and tablet demand impacting Corning’s optical components business. Citi also notes uncertainty about demand recovery for premium and large-size televisions.Market NewsBiden Says Weighs Reducing Tariffs on China, Asking OPEC to Pump More OilU.S. President Joe Biden said he was weighing cutting tariffs on Chinese goods while increasing calls on OPEC to raise oil production as he grappled with a politically damaging wave of inflation.\"I am considering it. We did not impose any of those tariffs. They were imposed by the last administration and they're under consideration,\" Biden said on reducing tariffs on China.Broadcom in Advanced Talks to Buy VMwareBroadcom Inc. is in advanced talks to buy VMware Inc., according to people familiar with the matter, setting the stage for what would be one of the year’s biggest deals.The technology companies are discussing a cash-and-stock deal that could come soon, assuming the talks don’t fall apart, the people said. VMware has a market value of $40 billion, while Broadcom’s is around $222 billion.The deal discussions, which picked up pace in recent days, come roughly six months after computing pioneer Dell Technologies Inc. spun off its 81% equity stake in VMware.","news_type":1},"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9063782576,"gmtCreate":1651536366472,"gmtModify":1676534920719,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] ","listText":"[Call] [Call] [Call] ","text":"[Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9063782576","repostId":"2232747831","repostType":2,"repost":{"id":"2232747831","kind":"highlight","pubTimestamp":1651539087,"share":"https://ttm.financial/m/news/2232747831?lang=&edition=fundamental","pubTime":"2022-05-03 08:51","market":"us","language":"en","title":"Why Novavax Stock Soared 19% on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2232747831","media":"Motley Fool","summary":"Investors remain optimistic about an upcoming FDA advisory committee meeting.","content":"<html><head></head><body><h2>What happened</h2><p>Shares of <b>Novavax</b> soared 19.3% on Monday. The gain continues the momentum that started on Friday after the Food and Drug Administration (FDA) announced plans to convene an advisory committee to review the Emergency Use Authorization (EUA) filing for Novavax's COVID-19 vaccine.</p><p><img src=\"https://static.tigerbbs.com/0ba44bbe01cf9039e71b5c2b15d4c05f\" tg-width=\"841\" tg-height=\"621\" width=\"100%\" height=\"auto\"/></p><p>Also, investors could be more optimistic about the near-term demand for COVID vaccines in general. Dr. Deborah Birx, the former White House Coronavirus Response Task Force coordinator, warned in an interview with CBS on Sunday that the southern U.S. could experience a summer surge of coronavirus cases.</p><h2>So what</h2><p>Some investors appear to be jumping back onto the Novavax bandwagon after the vaccine stock plunged more than 80% below its all-time high set last year. The meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) scheduled for June 7 certainly appears to be a hopeful sign that Novavax could at long last win EUA for its COVID vaccine, NVX-CoV2373.</p><p>Sure, the advisory committee must first deliberate. The FDA then has to make its decision on the authorization of NVX-CoV2373. But the likelihood of a thumbs-up seems to be greater than ever, as evidenced by the resurgence in Novavax's share price.</p><p>Dr. Birx's prediction of a surge in COVID cases probably isn't nearly as significant of a factor in Novavax's gains today. But it is possible that another coronavirus wave could bolster the prospects that the U.S. government could promote Novavax's protein sub-unit vaccine as an alternative for Americans who have been hesitant to receive messenger RNA vaccines.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d26561931e10f5ca9eea3a42da88654\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>Now what</h2><p>Novavax continues to work with the FDA in its EUA review process for NVX-CoV2373. It seems likely that the agency will quickly make a decision after the advisory committee meets based on the precedent set with other COVID vaccines.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Soared 19% on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Soared 19% on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-03 08:51 GMT+8 <a href=https://www.fool.com/investing/2022/05/02/why-novavax-stock-is-soaring-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happenedShares of Novavax soared 19.3% on Monday. The gain continues the momentum that started on Friday after the Food and Drug Administration (FDA) announced plans to convene an advisory ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/02/why-novavax-stock-is-soaring-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2022/05/02/why-novavax-stock-is-soaring-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2232747831","content_text":"What happenedShares of Novavax soared 19.3% on Monday. The gain continues the momentum that started on Friday after the Food and Drug Administration (FDA) announced plans to convene an advisory committee to review the Emergency Use Authorization (EUA) filing for Novavax's COVID-19 vaccine.Also, investors could be more optimistic about the near-term demand for COVID vaccines in general. Dr. Deborah Birx, the former White House Coronavirus Response Task Force coordinator, warned in an interview with CBS on Sunday that the southern U.S. could experience a summer surge of coronavirus cases.So whatSome investors appear to be jumping back onto the Novavax bandwagon after the vaccine stock plunged more than 80% below its all-time high set last year. The meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) scheduled for June 7 certainly appears to be a hopeful sign that Novavax could at long last win EUA for its COVID vaccine, NVX-CoV2373.Sure, the advisory committee must first deliberate. The FDA then has to make its decision on the authorization of NVX-CoV2373. But the likelihood of a thumbs-up seems to be greater than ever, as evidenced by the resurgence in Novavax's share price.Dr. Birx's prediction of a surge in COVID cases probably isn't nearly as significant of a factor in Novavax's gains today. But it is possible that another coronavirus wave could bolster the prospects that the U.S. government could promote Novavax's protein sub-unit vaccine as an alternative for Americans who have been hesitant to receive messenger RNA vaccines.Image source: Getty Images.Now whatNovavax continues to work with the FDA in its EUA review process for NVX-CoV2373. It seems likely that the agency will quickly make a decision after the advisory committee meets based on the precedent set with other COVID vaccines.","news_type":1},"isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9997682752,"gmtCreate":1661809424678,"gmtModify":1676536580028,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9997682752","repostId":"1182587354","repostType":2,"repost":{"id":"1182587354","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1661780991,"share":"https://ttm.financial/m/news/1182587354?lang=&edition=fundamental","pubTime":"2022-08-29 21:49","market":"us","language":"en","title":"Hot Chinese ADRs Gained in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1182587354","media":"Tiger Newspress","summary":"Hot Chinese ADRs Gained in Morning Trading.Alibaba, JD.com, Pinduoduo, Baidu, Nio, iQiyi, and RLX Te","content":"<html><head></head><body><p>Hot Chinese ADRs Gained in Morning Trading.</p><p><a href=\"https://laohu8.com/S/BABA\">Alibaba</a>, <a href=\"https://laohu8.com/S/JD\">JD.com</a>, <a href=\"https://laohu8.com/S/PDD\">Pinduoduo</a>, <a href=\"https://laohu8.com/S/BIDU\">Baidu</a>, <a href=\"https://laohu8.com/S/NIO\">Nio</a>, iQiyi, and <a href=\"https://laohu8.com/S/RLX\">RLX Technology</a> rose between 1% and 18%.<img src=\"https://static.tigerbbs.com/2407e5b2b87ae907aa70e31dbd95aa78\" tg-width=\"460\" tg-height=\"527\" referrerpolicy=\"no-referrer\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot Chinese ADRs Gained in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot Chinese ADRs Gained in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-08-29 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Hot Chinese ADRs Gained in Morning Trading.</p><p><a href=\"https://laohu8.com/S/BABA\">Alibaba</a>, <a href=\"https://laohu8.com/S/JD\">JD.com</a>, <a href=\"https://laohu8.com/S/PDD\">Pinduoduo</a>, <a href=\"https://laohu8.com/S/BIDU\">Baidu</a>, <a href=\"https://laohu8.com/S/NIO\">Nio</a>, iQiyi, and <a href=\"https://laohu8.com/S/RLX\">RLX Technology</a> rose between 1% and 18%.<img src=\"https://static.tigerbbs.com/2407e5b2b87ae907aa70e31dbd95aa78\" tg-width=\"460\" tg-height=\"527\" referrerpolicy=\"no-referrer\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK1517":"云办公","BIDU":"百度","BK1584":"蚂蚁金服概念","BK1575":"同股不同权","09988":"阿里巴巴-W","PDD":"拼多多","BK4531":"中概回港概念","09888":"百度集团-SW","BK4534":"瑞士信贷持仓","RLX":"雾芯科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4075":"烟草","BK4558":"双十一","BK4509":"腾讯概念","BK1588":"回港中概股","QNETCN":"纳斯达克中美互联网老虎指数","BABA":"阿里巴巴","09618":"京东集团-SW","JD":"京东","NIO":"蔚来","BK4565":"NFT概念","IQ":"爱奇艺"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182587354","content_text":"Hot Chinese ADRs Gained in Morning Trading.Alibaba, JD.com, Pinduoduo, Baidu, Nio, iQiyi, and RLX Technology rose between 1% and 18%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9998324696,"gmtCreate":1660950338618,"gmtModify":1676536426927,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9998324696","repostId":"2260793376","repostType":2,"repost":{"id":"2260793376","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1660952052,"share":"https://ttm.financial/m/news/2260793376?lang=&edition=fundamental","pubTime":"2022-08-20 07:34","market":"us","language":"en","title":"Novavax Gets Expanded Vaccine EUA From FDA for Ages 12-17","url":"https://stock-news.laohu8.com/highlight/detail?id=2260793376","media":"Dow Jones","summary":"Novavax Inc.'s Covid-19 vaccine, which became available in the U.S. in July for adults, has received","content":"<html><head></head><body><p>Novavax Inc.'s Covid-19 vaccine, which became available in the U.S. in July for adults, has received expanded emergency use authorization from the Food and Drug Administration, for people ages 12 through 17.</p><p>Doses will be available upon a favorable policy recommendation from the Centers for Disease Control and Prevention.</p><p>Novavax said the expanded EUA will "hopefully help increase vaccination rates, particularly as we prepare for ongoing surges of COVID-19 with the start of fall and the back-to-school season."</p><p>The company hopes its vaccine "may have a special role in adolescent vaccination based on parents' and caregivers' familiarity with protein-based vaccines used in other disease areas."</p><p>Novavax, which lowered 2022 sales guidance on Aug. 8, received New Zealand expanded provisional vaccine approval this week for ages 12 through 17.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Gets Expanded Vaccine EUA From FDA for Ages 12-17</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Gets Expanded Vaccine EUA From FDA for Ages 12-17\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-08-20 07:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Novavax Inc.'s Covid-19 vaccine, which became available in the U.S. in July for adults, has received expanded emergency use authorization from the Food and Drug Administration, for people ages 12 through 17.</p><p>Doses will be available upon a favorable policy recommendation from the Centers for Disease Control and Prevention.</p><p>Novavax said the expanded EUA will "hopefully help increase vaccination rates, particularly as we prepare for ongoing surges of COVID-19 with the start of fall and the back-to-school season."</p><p>The company hopes its vaccine "may have a special role in adolescent vaccination based on parents' and caregivers' familiarity with protein-based vaccines used in other disease areas."</p><p>Novavax, which lowered 2022 sales guidance on Aug. 8, received New Zealand expanded provisional vaccine approval this week for ages 12 through 17.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2260793376","content_text":"Novavax Inc.'s Covid-19 vaccine, which became available in the U.S. in July for adults, has received expanded emergency use authorization from the Food and Drug Administration, for people ages 12 through 17.Doses will be available upon a favorable policy recommendation from the Centers for Disease Control and Prevention.Novavax said the expanded EUA will \"hopefully help increase vaccination rates, particularly as we prepare for ongoing surges of COVID-19 with the start of fall and the back-to-school season.\"The company hopes its vaccine \"may have a special role in adolescent vaccination based on parents' and caregivers' familiarity with protein-based vaccines used in other disease areas.\"Novavax, which lowered 2022 sales guidance on Aug. 8, received New Zealand expanded provisional vaccine approval this week for ages 12 through 17.","news_type":1},"isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9905123991,"gmtCreate":1659839738515,"gmtModify":1703766963132,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9905123991","repostId":"2257249151","repostType":4,"repost":{"id":"2257249151","kind":"highlight","pubTimestamp":1659837878,"share":"https://ttm.financial/m/news/2257249151?lang=&edition=fundamental","pubTime":"2022-08-07 10:04","market":"us","language":"en","title":"Alibaba Has 1 Monster Hidden Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2257249151","media":"Motley Fool","summary":"Alibaba was set to IPO its stake in Ant Group in 2020 at a massive valuation. The company may be rekindling the IPO.","content":"<html><head></head><body><p><b>Alibaba</b> has taken steps that could revive an IPO of its Ant Group holding. Its previous attempt to bring the company public fetched an enormous valuation. Though its IPO was pulled off the table, Alibaba still owns a significant interest in the valuable company. Here's what's happening now.</p><h2>Hidden gem</h2><p>Ant Group operates a digital payment app branded as Alipay. The company was founded by Jack Ma, who also founded Alibaba. Alipay's 1.3 billion users transact on Alibaba's e-commerce websites and anywhere mobile payments are accepted. The app also allows users to access its money market fund, its buy now, pay later service, and online banking. Alibaba owns 33% of Ant Group.</p><p>In 2020, Ant planned to IPO as a stand-alone company, which would've valued the fast-growing company at over $300 billion. At that time, Ant Group would've been larger than U.S. banks <b>Wells Fargo</b> and <b>Goldman Sachs</b>.</p><p>Unfortunately for Ant shareholders, the IPO was scrapped at the last minute by the Chinese government, which began to issue sweeping regulations on Chinese tech companies, like Ant, that performed financial services but were not regulated like financial institutions. Many Chinese stocks, including Alibaba, began a precipitous fall. Alibaba shares fell from over $300 per share in October 2020 to their current price of around $90.</p><h2>Is Alibaba stock a buy right now?</h2><p>If Ant Group is worth over $300 billion, which it was valued at before its ill-fated IPO, Alibaba's one-third stake would be worth about $100 billion. On top of that, Alibaba's primary businesses include its popular e-commerce platform and rapid-growth cloud business, which holds 5% of the global cloud market.</p><p>Altogether, Alibaba pulled in $9.7 billion of net income in its year ended March 31, 2022. So, using its five-year average P/E ratio of 32 times as a proxy, Alibaba should be worth $310 billion. Adding the company's $100 billion stake in Ant Group would bring Alibaba's total value to approximately $410 billion. Alibaba's current market cap is only $275 billion, which may represent a significant value opportunity to shareholders.</p><p>Chinese fintech regulation was one cause of the share price's decimation, but it would appear those issues are behind the company. Shareholders are now grappling with a potential delisting of Alibaba shares from American stock exchanges. The problem with delisting is that many large institutional investment companies cannot hold shares of companies not listed on a major exchange.</p><p>Many of those investors may already be out of the stock, presenting an opportunity for individual investors able to hold shares if they move to the OTC markets or foreign exchanges. An IPO of Ant Group may be a catalyst for the market to recognize Alibaba shares' hidden value, potentially keeping it from being delisted.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba Has 1 Monster Hidden Asset</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba Has 1 Monster Hidden Asset\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-07 10:04 GMT+8 <a href=https://www.fool.com/investing/2022/08/06/alibaba-has-1-monster-hidden-asset/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Alibaba has taken steps that could revive an IPO of its Ant Group holding. Its previous attempt to bring the company public fetched an enormous valuation. Though its IPO was pulled off the table, ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/08/06/alibaba-has-1-monster-hidden-asset/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2022/08/06/alibaba-has-1-monster-hidden-asset/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2257249151","content_text":"Alibaba has taken steps that could revive an IPO of its Ant Group holding. Its previous attempt to bring the company public fetched an enormous valuation. Though its IPO was pulled off the table, Alibaba still owns a significant interest in the valuable company. Here's what's happening now.Hidden gemAnt Group operates a digital payment app branded as Alipay. The company was founded by Jack Ma, who also founded Alibaba. Alipay's 1.3 billion users transact on Alibaba's e-commerce websites and anywhere mobile payments are accepted. The app also allows users to access its money market fund, its buy now, pay later service, and online banking. Alibaba owns 33% of Ant Group.In 2020, Ant planned to IPO as a stand-alone company, which would've valued the fast-growing company at over $300 billion. At that time, Ant Group would've been larger than U.S. banks Wells Fargo and Goldman Sachs.Unfortunately for Ant shareholders, the IPO was scrapped at the last minute by the Chinese government, which began to issue sweeping regulations on Chinese tech companies, like Ant, that performed financial services but were not regulated like financial institutions. Many Chinese stocks, including Alibaba, began a precipitous fall. Alibaba shares fell from over $300 per share in October 2020 to their current price of around $90.Is Alibaba stock a buy right now?If Ant Group is worth over $300 billion, which it was valued at before its ill-fated IPO, Alibaba's one-third stake would be worth about $100 billion. On top of that, Alibaba's primary businesses include its popular e-commerce platform and rapid-growth cloud business, which holds 5% of the global cloud market.Altogether, Alibaba pulled in $9.7 billion of net income in its year ended March 31, 2022. So, using its five-year average P/E ratio of 32 times as a proxy, Alibaba should be worth $310 billion. Adding the company's $100 billion stake in Ant Group would bring Alibaba's total value to approximately $410 billion. Alibaba's current market cap is only $275 billion, which may represent a significant value opportunity to shareholders.Chinese fintech regulation was one cause of the share price's decimation, but it would appear those issues are behind the company. Shareholders are now grappling with a potential delisting of Alibaba shares from American stock exchanges. The problem with delisting is that many large institutional investment companies cannot hold shares of companies not listed on a major exchange.Many of those investors may already be out of the stock, presenting an opportunity for individual investors able to hold shares if they move to the OTC markets or foreign exchanges. An IPO of Ant Group may be a catalyst for the market to recognize Alibaba shares' hidden value, potentially keeping it from being delisted.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9905162842,"gmtCreate":1659839441389,"gmtModify":1703766953844,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9905162842","repostId":"2257173007","repostType":2,"repost":{"id":"2257173007","kind":"highlight","pubTimestamp":1659844923,"share":"https://ttm.financial/m/news/2257173007?lang=&edition=fundamental","pubTime":"2022-08-07 12:02","market":"us","language":"en","title":"Apple: Is Advertising the Next Big Revenue Generator? Analyst Weighs In","url":"https://stock-news.laohu8.com/highlight/detail?id=2257173007","media":"TipRanks","summary":"The Apple (AAPL) empire might be spearheaded by its flagship product, the iPhone, but along with ple","content":"<div>\n<p>The Apple (AAPL) empire might be spearheaded by its flagship product, the iPhone, but along with plenty of other hardware offerings, its Services segment has been growing at a fast pace. There’s also ...</p>\n\n<a href=\"https://finance.yahoo.com/news/apple-advertising-next-big-revenue-171806739.html\">Web Link</a>\n\n</div>\n","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: Is Advertising the Next Big Revenue Generator? Analyst Weighs In</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: Is Advertising the Next Big Revenue Generator? Analyst Weighs In\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-07 12:02 GMT+8 <a href=https://finance.yahoo.com/news/apple-advertising-next-big-revenue-171806739.html><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Apple (AAPL) empire might be spearheaded by its flagship product, the iPhone, but along with plenty of other hardware offerings, its Services segment has been growing at a fast pace. There’s also ...</p>\n\n<a href=\"https://finance.yahoo.com/news/apple-advertising-next-big-revenue-171806739.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://finance.yahoo.com/news/apple-advertising-next-big-revenue-171806739.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2257173007","content_text":"The Apple (AAPL) empire might be spearheaded by its flagship product, the iPhone, but along with plenty of other hardware offerings, its Services segment has been growing at a fast pace. There’s also talk of a “game changing” AV/VR headset and even of an Apple Car at some point.But Needham analyst Laura Martin thinks there’s also the prospect of another big revenue stream.“We believe AAPL is in the early stages of building a new mobile advertising platform,” says Martin, who thinks ad revenue could be a “material upside value driver” for the tech giant for several reasons.For one, there’s the offensive element. Apple being the largest company in the world, to keep on growing it must focus on big global TAMs (total addressable markets). As eMarketer expects the global digital advertising market to reach $600 billion this year, it certainly qualifies as one.There’s also a defensive element, as explained by Martin: “Creating a privacy-first ad platform would solve a problem for AAPL's ad-driven apps which have seen their ad revs fall after iOS replaced IDFA with ATT in 3Q21.”It also amounts to a clever tactical move. Apple operates as a “Walled Garden” and its user data is “best-in-class.” All the while, it is also reducing the tracking and transparency data accessible to other companies. This gives the company’s “pricing power” a boost.Martin is not just speculating on the matter. There’s evidence of Apple's advertising ambitions, as the company's recent job postings imply a new AdTech platform is being built. Since the early months of the year, there has been a notable increase in the company’s recruiting activity for its Ad Platform unit. Just recently, Apple put up a job opening for \"a senior manager for its DSP in its ads platforms business who will drive the design of the most privacy-forward, sophisticated demand side platform possible.\" Moreover, Apple made its presence felt during June’s Cannes Lions advertising festival. This suggests to Martin, the company is trying to “drive awareness among marketers that it is in the advertising business.”So, down to the nitty-gritty, what does it all mean for investors? Martin reiterated a Buy rating on Apple shares, backed by a $170 price target, suggesting shares are fairly valued right now.The Street’s average target is a touch higher; at $180.11, the figure leaves room for a 9% upside from current levels. All told, based on 22 Buys, 6 Holds and 1 Sell, the stock claims a Moderate Buy consensus rating.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9906047092,"gmtCreate":1659476403918,"gmtModify":1705980597474,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"Noted.","listText":"Noted.","text":"Noted.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9906047092","repostId":"1188690484","repostType":4,"repost":{"id":"1188690484","kind":"news","pubTimestamp":1659454673,"share":"https://ttm.financial/m/news/1188690484?lang=&edition=fundamental","pubTime":"2022-08-02 23:37","market":"us","language":"en","title":"Alibaba: Be Greedy When Others Are Fearful","url":"https://stock-news.laohu8.com/highlight/detail?id=1188690484","media":"Seeking Alpha","summary":"SummaryAlibaba has grown at a 5-year CAGR of more than 42%, but the company's stock is trading at a ","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Alibaba has grown at a 5-year CAGR of more than 42%, but the company's stock is trading at a PE of about x17.</li><li>The stock is down about 70% from ATH and now trades at very attractive risk/reward levels.</li><li>Personally, I see more than 50% upside for BABA stock, as I calculate the company's fair value with a residual earnings model.</li></ul><p><b>Thesis</b></p><p>I am very bullish on Alibaba (NYSE:BABA) stock. I strongly believe that the market has priced in too much negativity and pessimism as compared to reality and investors are well advised to follow one of Buffett's key maxims:</p><blockquote>Be greedy when others are fearful.</blockquote><p>Alibaba has grown at a 5-year CAGR of more than 42%, but the company's stock is trading at a PE of about x17. This indicates a clear undervaluation.</p><p>Of course, I understand that investors are worried about a potential ADR delisting, slowing economy and crackdown on internet/tech companies. However, just like a bull market tops on the most bullish conditions, a bear market bottoms on the most bearish conditions. While investors should study and understand the risks, I personally believe that Alibaba stock will rebound strongly from current price levels of below $100/share.</p><p>Personally, I see more than 50% upside for BABA stock, as I calculate the company's fair value with a residual earnings model anchored on fundamentals and analyst consensus estimates. My target price is $133.92.</p><p><b>A Best-In-Class Company</b></p><p>Alibaba is one of the biggest e-commerce companies in the world. The company operates three main shopping sites Taobao, Tmall and Alibaba.com, which cumulatively serve some 828 million monthly active buyers (fiscal year ending March 31, 2021).</p><p>Alibaba also has stakes in multiple innovative internet/technology businesses such as Youku (video entertainment), Pony.Ai (Autonomous Driving) and most notably Ant Group (The world's biggest financial service company). Alipay serves almost the entire population in China. The platform has 1.3 billion users and 80 million merchants. Notably, the total payment volume of Alipay was more than $19 trillion in 2021.</p><p>Moreover, Alibaba is a dominant force in China's cloud market with about37% market share. China's cloud market is expected to grow at a 4-year CAGR of more than 25%, reaching $85 billion in 2026. As the market leader in China, Alibaba is poised to benefit from this super-charged cloud-growth. Cloud is also a business vertical where the company should enjoy government tailwind, as the Chinese Communist Party is actively supporting digitalization efforts of the economy and has made cloud development a key-priority in the party's5-year development plan.</p><p><b>Bullish Financials</b></p><p>In the past financial year, the Alibaba Group generated total revenues of about $134.5 billion and recorded an operating income of about $15 billion. Most notably in the past five years, from March 2017 to March 2022, Alibaba has grown at an unbelievable 5-year CAGR of 42%. For reference, this is almost double the growth rate of Amazon, which grew at a 5-year CAGR of 22% CAGR over the same period. Alibaba closed the fiscal year 2021 with 9.8 billion of net-income available to common shareholders.</p><p>Alibaba'sbalance sheet is very strong: As of March 2022, the company recorded $71.7 billion of cash and cash equivalents and only $27.85 of total financial debt. This makes Alibaba a net-creditor of about $43 billion -- which is 17% of the company's market capitalization. Moreover, Alibaba's business operations, despite the strong growth, are cash-accretive. In fiscal 2021, the company generated cash from operations of $22.5 billion. Under these circumstances it should come to no surprise that the company announced a $25 billion share-buyback program, more than 10% of the outstanding shares) in March 2022.</p><p>Alibaba will announce earnings for the quarter from April to end of June on August 4th before the market open. Analyst consensus expects total revenues of $30.21 billion and EPS of $1.56.</p><p><b>The Buying Opportunity</b></p><p>Despite the strong business fundamentals, Alibaba stock suffered a spectacular sell-off. BABA shares are down about 70% from ATH as the company was pressured by multiple headwinds: ADR delisting fears, as slowing economy , Covid-19 lockdowns and an aggressive regulatory crackdown that started with the cancellation of the Ant Group IPO in November 2020.</p><p><img src=\"https://static.tigerbbs.com/c01e6eab7204bcc90b5af9aa0d87ac85\" tg-width=\"640\" tg-height=\"232\" referrerpolicy=\"no-referrer\"/></p><p>Seeking Alpha</p><p>Alibaba is a quality company, and the stock's undervaluation is no secret to investors. The key-question is: is the worst behind, and can investors safely invest in Alibaba stock?</p><p>I strongly believe that a safe investment does not exist. In my opinion, every investment opportunity must be judged as a function of its price. And the lower the price, the less risky an investment becomes. Thus, investing is a question of risk/reward. Given Alibaba's extremely depressed valuation - now the company's stock is trading at a PE of about x17- I argue an investment is justified.</p><p>Moreover, there are signs that all of Alibaba's headwinds are easing and the negativity surrounding the stock has peaked. China has on multiple occasions tried to communicate to investors that the internet/technology crackdown is coming to an end and is actively supporting the healthy expansion of digital platform economies.</p><p>In addition, China has vowed to push more fiscal economic support- with a special focus on digitalization. While western economies are hawkish on fiscal and monetary stimulus - ending a decade long easing cycle, China is one of the few economies that appears to start a new stimulus cycle.</p><p>Analysts agree with the bullish thesis. In general, analysts are very bullish on Alibaba stock. Based on ratings of 44 analysts, 33 analysts give a Strong Buy rating, 8 are Buy rated and 3 assign a Hold recommendation. There is no Sell or Strong Sell rating. The average price target is $155.47/share, indicating more than 70% upside.</p><p><img src=\"https://static.tigerbbs.com/8fa3c940aeeed4780c87b1ca71bdb180\" tg-width=\"640\" tg-height=\"228\" referrerpolicy=\"no-referrer\"/></p><p>Seeking Alpha</p><p><b>Residual Earnings Valuation</b></p><p>Let us now look at the valuation. What could be a fair per-share value for Alibaba stock? To answer the question, I have constructed a Residual Earnings framework and anchor on the following assumptions:</p><ul><li>To forecast EPS, I anchor on consensus analyst forecast as available on the Bloomberg Terminal 'till 2025. In my opinion, any estimate beyond 2025 is too speculative to include in a valuation framework. But for 2-3 years, analyst consensus is usually quite precise.</li><li>To estimate the cost of capital, I use the WACC framework. I model a three-year regression against the Hang Seng to find the stock's beta. For the risk-free rate, I used the U.S. 10-year treasury yield as of July 22nd, 2022. My calculation indicates a fair WACC of about 9.8%. I adjust upward to 12% in order to reflect the company's idiosyncratic market risk.</li><li>To derive Baidu's tax rate, I extrapolate the 3-year average effective tax-rate from 2019, 2020 and 2021.</li><li>For the terminal growth rate, I apply expected nominal GDP growth plus one percentage point to reflect a favorable growth outlook for Alibaba's high-potential initiatives</li><li>I do not model any share buyback further supporting a conservative valuation.</li></ul><p>Based on the above assumptions, my calculation returns a base-case target price for Alibaba of $133.92/share, implying material upside of more than 50%.</p><p><img src=\"https://static.tigerbbs.com/b7cb860aca7fa48ef2afe7e265d3effa\" tg-width=\"640\" tg-height=\"229\" referrerpolicy=\"no-referrer\"/></p><p>Analyst Consensus EPS; Author's Calculation</p><p>I understand that investors might have different assumptions with regards to Alibaba's required return and terminal business growth. Thus, I also enclose a sensitivity table to test varying assumptions. For reference, red-cells imply an overvaluation as compared to the current market price, and green-cells imply an undervaluation. Notably, all tested combinations imply an undervaluation!</p><p><img src=\"https://static.tigerbbs.com/62ba3323a1f09e75477921298d84cbf8\" tg-width=\"640\" tg-height=\"154\" referrerpolicy=\"no-referrer\"/></p><p>Analyst Consensus EPS; Author's Calculation</p><p><b>Investment Risks</b></p><p>Investors should be aware of the following downside risks that might cause Alibaba stock to materially deviate from my base-case target price of $133.92/share:</p><p>First, the economy is currently pressured by multiple headwinds including inflation, real-estate crisis and COVID-19 lockdowns. If the economy would slow more than what is expected and priced in, investors should adjust expectations for Alibaba's short/mid-term business monetization accordingly.</p><p>Secondly, China's internet/tech companies are strongly exposed to regulatory risk. While the worst seems to be behind us, the elevated risk exposure persists -- and will arguably never completely fade.</p><p>Third, much of BABA's share price volatility is currently driven by investor sentiment towards Chinese ADRs and risk assets. Thus, BABA stock price might show strong price volatility even though the company's business fundamentals remain unchanged.</p><p><b>Conclusion</b></p><p>Alibaba stock is down 70% from ATH, but the company remains a global powerhouse with enormous long-term potential. Trading at a PE of below x17, despite growing like a start-up, I argue Alibaba's sell-off could offer long-term focused investors, that can stomach short term share-price volatility, a generational buying opportunity.</p><p>Personally, I see more than 50% upside for BABA stock, despite cautious and conservative valuation assumptions. Strong Buy.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Be Greedy When Others Are Fearful</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Be Greedy When Others Are Fearful\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-02 23:37 GMT+8 <a href=https://seekingalpha.com/article/4528176-alibaba-be-greedy-when-others-fearful><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba has grown at a 5-year CAGR of more than 42%, but the company's stock is trading at a PE of about x17.The stock is down about 70% from ATH and now trades at very attractive risk/reward ...</p>\n\n<a href=\"https://seekingalpha.com/article/4528176-alibaba-be-greedy-when-others-fearful\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4528176-alibaba-be-greedy-when-others-fearful","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188690484","content_text":"SummaryAlibaba has grown at a 5-year CAGR of more than 42%, but the company's stock is trading at a PE of about x17.The stock is down about 70% from ATH and now trades at very attractive risk/reward levels.Personally, I see more than 50% upside for BABA stock, as I calculate the company's fair value with a residual earnings model.ThesisI am very bullish on Alibaba (NYSE:BABA) stock. I strongly believe that the market has priced in too much negativity and pessimism as compared to reality and investors are well advised to follow one of Buffett's key maxims:Be greedy when others are fearful.Alibaba has grown at a 5-year CAGR of more than 42%, but the company's stock is trading at a PE of about x17. This indicates a clear undervaluation.Of course, I understand that investors are worried about a potential ADR delisting, slowing economy and crackdown on internet/tech companies. However, just like a bull market tops on the most bullish conditions, a bear market bottoms on the most bearish conditions. While investors should study and understand the risks, I personally believe that Alibaba stock will rebound strongly from current price levels of below $100/share.Personally, I see more than 50% upside for BABA stock, as I calculate the company's fair value with a residual earnings model anchored on fundamentals and analyst consensus estimates. My target price is $133.92.A Best-In-Class CompanyAlibaba is one of the biggest e-commerce companies in the world. The company operates three main shopping sites Taobao, Tmall and Alibaba.com, which cumulatively serve some 828 million monthly active buyers (fiscal year ending March 31, 2021).Alibaba also has stakes in multiple innovative internet/technology businesses such as Youku (video entertainment), Pony.Ai (Autonomous Driving) and most notably Ant Group (The world's biggest financial service company). Alipay serves almost the entire population in China. The platform has 1.3 billion users and 80 million merchants. Notably, the total payment volume of Alipay was more than $19 trillion in 2021.Moreover, Alibaba is a dominant force in China's cloud market with about37% market share. China's cloud market is expected to grow at a 4-year CAGR of more than 25%, reaching $85 billion in 2026. As the market leader in China, Alibaba is poised to benefit from this super-charged cloud-growth. Cloud is also a business vertical where the company should enjoy government tailwind, as the Chinese Communist Party is actively supporting digitalization efforts of the economy and has made cloud development a key-priority in the party's5-year development plan.Bullish FinancialsIn the past financial year, the Alibaba Group generated total revenues of about $134.5 billion and recorded an operating income of about $15 billion. Most notably in the past five years, from March 2017 to March 2022, Alibaba has grown at an unbelievable 5-year CAGR of 42%. For reference, this is almost double the growth rate of Amazon, which grew at a 5-year CAGR of 22% CAGR over the same period. Alibaba closed the fiscal year 2021 with 9.8 billion of net-income available to common shareholders.Alibaba'sbalance sheet is very strong: As of March 2022, the company recorded $71.7 billion of cash and cash equivalents and only $27.85 of total financial debt. This makes Alibaba a net-creditor of about $43 billion -- which is 17% of the company's market capitalization. Moreover, Alibaba's business operations, despite the strong growth, are cash-accretive. In fiscal 2021, the company generated cash from operations of $22.5 billion. Under these circumstances it should come to no surprise that the company announced a $25 billion share-buyback program, more than 10% of the outstanding shares) in March 2022.Alibaba will announce earnings for the quarter from April to end of June on August 4th before the market open. Analyst consensus expects total revenues of $30.21 billion and EPS of $1.56.The Buying OpportunityDespite the strong business fundamentals, Alibaba stock suffered a spectacular sell-off. BABA shares are down about 70% from ATH as the company was pressured by multiple headwinds: ADR delisting fears, as slowing economy , Covid-19 lockdowns and an aggressive regulatory crackdown that started with the cancellation of the Ant Group IPO in November 2020.Seeking AlphaAlibaba is a quality company, and the stock's undervaluation is no secret to investors. The key-question is: is the worst behind, and can investors safely invest in Alibaba stock?I strongly believe that a safe investment does not exist. In my opinion, every investment opportunity must be judged as a function of its price. And the lower the price, the less risky an investment becomes. Thus, investing is a question of risk/reward. Given Alibaba's extremely depressed valuation - now the company's stock is trading at a PE of about x17- I argue an investment is justified.Moreover, there are signs that all of Alibaba's headwinds are easing and the negativity surrounding the stock has peaked. China has on multiple occasions tried to communicate to investors that the internet/technology crackdown is coming to an end and is actively supporting the healthy expansion of digital platform economies.In addition, China has vowed to push more fiscal economic support- with a special focus on digitalization. While western economies are hawkish on fiscal and monetary stimulus - ending a decade long easing cycle, China is one of the few economies that appears to start a new stimulus cycle.Analysts agree with the bullish thesis. In general, analysts are very bullish on Alibaba stock. Based on ratings of 44 analysts, 33 analysts give a Strong Buy rating, 8 are Buy rated and 3 assign a Hold recommendation. There is no Sell or Strong Sell rating. The average price target is $155.47/share, indicating more than 70% upside.Seeking AlphaResidual Earnings ValuationLet us now look at the valuation. What could be a fair per-share value for Alibaba stock? To answer the question, I have constructed a Residual Earnings framework and anchor on the following assumptions:To forecast EPS, I anchor on consensus analyst forecast as available on the Bloomberg Terminal 'till 2025. In my opinion, any estimate beyond 2025 is too speculative to include in a valuation framework. But for 2-3 years, analyst consensus is usually quite precise.To estimate the cost of capital, I use the WACC framework. I model a three-year regression against the Hang Seng to find the stock's beta. For the risk-free rate, I used the U.S. 10-year treasury yield as of July 22nd, 2022. My calculation indicates a fair WACC of about 9.8%. I adjust upward to 12% in order to reflect the company's idiosyncratic market risk.To derive Baidu's tax rate, I extrapolate the 3-year average effective tax-rate from 2019, 2020 and 2021.For the terminal growth rate, I apply expected nominal GDP growth plus one percentage point to reflect a favorable growth outlook for Alibaba's high-potential initiativesI do not model any share buyback further supporting a conservative valuation.Based on the above assumptions, my calculation returns a base-case target price for Alibaba of $133.92/share, implying material upside of more than 50%.Analyst Consensus EPS; Author's CalculationI understand that investors might have different assumptions with regards to Alibaba's required return and terminal business growth. Thus, I also enclose a sensitivity table to test varying assumptions. For reference, red-cells imply an overvaluation as compared to the current market price, and green-cells imply an undervaluation. Notably, all tested combinations imply an undervaluation!Analyst Consensus EPS; Author's CalculationInvestment RisksInvestors should be aware of the following downside risks that might cause Alibaba stock to materially deviate from my base-case target price of $133.92/share:First, the economy is currently pressured by multiple headwinds including inflation, real-estate crisis and COVID-19 lockdowns. If the economy would slow more than what is expected and priced in, investors should adjust expectations for Alibaba's short/mid-term business monetization accordingly.Secondly, China's internet/tech companies are strongly exposed to regulatory risk. While the worst seems to be behind us, the elevated risk exposure persists -- and will arguably never completely fade.Third, much of BABA's share price volatility is currently driven by investor sentiment towards Chinese ADRs and risk assets. Thus, BABA stock price might show strong price volatility even though the company's business fundamentals remain unchanged.ConclusionAlibaba stock is down 70% from ATH, but the company remains a global powerhouse with enormous long-term potential. Trading at a PE of below x17, despite growing like a start-up, I argue Alibaba's sell-off could offer long-term focused investors, that can stomach short term share-price volatility, a generational buying opportunity.Personally, I see more than 50% upside for BABA stock, despite cautious and conservative valuation assumptions. Strong Buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9043642434,"gmtCreate":1655935534128,"gmtModify":1676535732589,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9043642434","repostId":"1117668692","repostType":2,"repost":{"id":"1117668692","kind":"news","pubTimestamp":1655890303,"share":"https://ttm.financial/m/news/1117668692?lang=&edition=fundamental","pubTime":"2022-06-22 17:31","market":"hk","language":"en","title":"Jack Ma’s Ant to Apply for Key License as Soon as This Month","url":"https://stock-news.laohu8.com/highlight/detail?id=1117668692","media":"Bloomberg","summary":"Central bank plans to accept Ant’s application, begin reviewMoves would clear path to potential revi","content":"<html><head></head><body><ul><li>Central bank plans to accept Ant’s application, begin review</li><li>Moves would clear path to potential revival of Ant’s IPO plan</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6954d9eae1684b8c174f53b669dfa677\" tg-width=\"1000\" tg-height=\"667\" referrerpolicy=\"no-referrer\"/><span>A barrier tape outside an Ant Group Co. office building in Shanghai, China.Photographer: Qilai Shen/Bloomberg</span></p><p>Jack Ma’s Ant Group Co. is poised to apply for a key financial license as soon as this month, according to people familiar with the matter, a sign that its lengthy overhaul following a squashed 2020 listing is getting closer to satisfying China’s financial regulators.</p><p>The People’s Bank of China intends to accept Ant’s application to become a financial holding company once it’s submitted and will then start a review process, which could take months, said the people, asking not to be identified discussing a private matter. Officials will examine Ant’s capital strength and business plans, as well as the compliance of its shareholders and senior management before a final signoff.</p><p>The moves would mark a crucial development in Ant’s revamp, affirming that the company can maintain its financial operations under the supervision of the central bank. While that clears a path for it to eventually revive a public offering, Ma’s fintech juggernaut will be a much diminished enterprise, with policy makers dramatically curbing its growth in consumer finance and its ability to leverage its ubiquitous payments app.</p><p>Shares of Alibaba Group Holding Ltd., which owns a third of Ant, have swung wildly in recent days as investors try to gauge how close policy makers are to concluding their examination of Ant’s operations. The stock climbed Friday after Reuters reported that Ant’s application for a financial holding company had been accepted, before giving up most of the gains when state-backed media refuted the report, citing people close to the central bank.</p><p>Dialing down scrutiny of Ant would offer powerful evidence that policy makers are following through on pledges to support the industry.</p><p>“Ant has been steadily moving forward with its rectification work according to regulatory requirements, including preparing materials to apply to set up a financial holding company,” a spokesperson for the company said in an emailed response to questions. “We do not have a timetable to submit this application.”</p><p>The PBOC didn’t immediately respond to a request seeking comment.</p><p>Under the official framework laid down last year, Ant needs to fold all its financial units into a holding company and be regulated like a bank with more scrutiny on its shareholder structure and tougher capital requirements. The PBOC has so far accepted five applications for financial holding firms and approved two of them after at least six months of review.</p><p>The crushing of Ant’s $35 billion IPO in November 2020 sent shock waves across the financial world, burning investment firms from Carlyle Group Inc. to Temasek Holdings Pte that had expected a windfall. It also marked the beginning of a broader regulation that ensnared some of China’s fastest-growing companies, erased more than $1 trillion of market value.</p><p>What Bloomberg Intelligence Says:</p><blockquote>“Its growth potential has weakened after regulatory steps including firewalls in Alipay’s ecosystem. Its valuation may have fallen to 20% of its $320 billion target at its last IPO attempt.”</blockquote><blockquote>--Francis Chan, banking & fintech analyst</blockquote><p>While investors are likely to welcome any signs that the tech regulation is easing, a return to the heady days of old appears unlikely. Myriad regulations imposed on Ant over the past two years mean the company is worth a fraction of its former self, according to some early backers. Fidelity Investments, for instance, slashed its valuation estimate for the firm to about $78 billion last June from $235 billion just before the IPO was abruptly suspended.</p><p>Regulators now have routine inspections to examine dealings between Ant and financial institutions, and continue to curb how much they can jointly lend. Before the crackdown, Ant had a thriving business doling out small unsecured loans in partnership with banks via its Huabei and Jiebei brands. Overall, its CreditTech business was its single biggest revenue maker, contributing 39% of the total in the first half of 2020.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jack Ma’s Ant to Apply for Key License as Soon as This Month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJack Ma’s Ant to Apply for Key License as Soon as This Month\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-22 17:31 GMT+8 <a href=https://www.bloomberg.com/news/articles/2022-06-22/jack-ma-s-ant-to-apply-for-key-license-as-soon-as-this-month?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Central bank plans to accept Ant’s application, begin reviewMoves would clear path to potential revival of Ant’s IPO planA barrier tape outside an Ant Group Co. office building in Shanghai, China....</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-06-22/jack-ma-s-ant-to-apply-for-key-license-as-soon-as-this-month?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-W"},"source_url":"https://www.bloomberg.com/news/articles/2022-06-22/jack-ma-s-ant-to-apply-for-key-license-as-soon-as-this-month?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117668692","content_text":"Central bank plans to accept Ant’s application, begin reviewMoves would clear path to potential revival of Ant’s IPO planA barrier tape outside an Ant Group Co. office building in Shanghai, China.Photographer: Qilai Shen/BloombergJack Ma’s Ant Group Co. is poised to apply for a key financial license as soon as this month, according to people familiar with the matter, a sign that its lengthy overhaul following a squashed 2020 listing is getting closer to satisfying China’s financial regulators.The People’s Bank of China intends to accept Ant’s application to become a financial holding company once it’s submitted and will then start a review process, which could take months, said the people, asking not to be identified discussing a private matter. Officials will examine Ant’s capital strength and business plans, as well as the compliance of its shareholders and senior management before a final signoff.The moves would mark a crucial development in Ant’s revamp, affirming that the company can maintain its financial operations under the supervision of the central bank. While that clears a path for it to eventually revive a public offering, Ma’s fintech juggernaut will be a much diminished enterprise, with policy makers dramatically curbing its growth in consumer finance and its ability to leverage its ubiquitous payments app.Shares of Alibaba Group Holding Ltd., which owns a third of Ant, have swung wildly in recent days as investors try to gauge how close policy makers are to concluding their examination of Ant’s operations. The stock climbed Friday after Reuters reported that Ant’s application for a financial holding company had been accepted, before giving up most of the gains when state-backed media refuted the report, citing people close to the central bank.Dialing down scrutiny of Ant would offer powerful evidence that policy makers are following through on pledges to support the industry.“Ant has been steadily moving forward with its rectification work according to regulatory requirements, including preparing materials to apply to set up a financial holding company,” a spokesperson for the company said in an emailed response to questions. “We do not have a timetable to submit this application.”The PBOC didn’t immediately respond to a request seeking comment.Under the official framework laid down last year, Ant needs to fold all its financial units into a holding company and be regulated like a bank with more scrutiny on its shareholder structure and tougher capital requirements. The PBOC has so far accepted five applications for financial holding firms and approved two of them after at least six months of review.The crushing of Ant’s $35 billion IPO in November 2020 sent shock waves across the financial world, burning investment firms from Carlyle Group Inc. to Temasek Holdings Pte that had expected a windfall. It also marked the beginning of a broader regulation that ensnared some of China’s fastest-growing companies, erased more than $1 trillion of market value.What Bloomberg Intelligence Says:“Its growth potential has weakened after regulatory steps including firewalls in Alipay’s ecosystem. Its valuation may have fallen to 20% of its $320 billion target at its last IPO attempt.”--Francis Chan, banking & fintech analystWhile investors are likely to welcome any signs that the tech regulation is easing, a return to the heady days of old appears unlikely. Myriad regulations imposed on Ant over the past two years mean the company is worth a fraction of its former self, according to some early backers. Fidelity Investments, for instance, slashed its valuation estimate for the firm to about $78 billion last June from $235 billion just before the IPO was abruptly suspended.Regulators now have routine inspections to examine dealings between Ant and financial institutions, and continue to curb how much they can jointly lend. Before the crackdown, Ant had a thriving business doling out small unsecured loans in partnership with banks via its Huabei and Jiebei brands. Overall, its CreditTech business was its single biggest revenue maker, contributing 39% of the total in the first half of 2020.","news_type":1},"isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9029498992,"gmtCreate":1652822058916,"gmtModify":1676535165777,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Like] [Like] [Like] ","listText":"[Like] [Like] [Like] ","text":"[Like] [Like] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9029498992","repostId":"1150378774","repostType":4,"repost":{"id":"1150378774","kind":"news","pubTimestamp":1652801386,"share":"https://ttm.financial/m/news/1150378774?lang=&edition=fundamental","pubTime":"2022-05-17 23:29","market":"us","language":"en","title":"5 Cathie Wood Stocks to Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1150378774","media":"InvestorPlace","summary":"Despite recent declines in share prices, these Cathie Wood stocks are strong plays on innovation, a ","content":"<html><head></head><body><ul><li>Despite recent declines in share prices, these Cathie Wood stocks are strong plays on innovation, a key driver of the global economy.</li><li><b>Block</b>(<b><u>SQ</u></b>) — The launch of Square Loans in Canada as well as the new generation of the Square Stand could provide a significant path to revenue growth.</li><li><b>CRISPR Therapeutics</b>(<b><u>CRSP</u></b>) — Substantial global investment in genetic engineering is likely to pave the way for tremendous growth.</li><li><b>Shopify</b>(<b><u>SHOP</u></b>) — The recent acquisition of <b>Deliverr</b> is likely to improve logistics operations and increase efficiency.</li><li><b>ARK Autonomous Technology & Robotics ETF</b>(<b><u>ARKQ</u></b>) — The exchange-traded fund, which has lost over a third of its value in 2022, offers better opportunities now.</li><li><b>ARK Space Exploration & Innovation ETF</b>(<b><u>ARKX</u></b>) — The fund invests in firms that are at the forefront of aerospace and space-related technologies.</li></ul><p>Cathie Wood stocks, our topic for today, have come under fire in 2022. Yet, during the pandemic, ARK Invest funds, led by Wood’s team, had generated tremendous buzz on Wall Street. The firm’s exchange-traded funds (ETFs), which seek long-term capital growth, focus mainly on disruptive innovation.</p><p>However, 2022 has proved a tough year for such high-growth shares. Concerns over the possibility of a recession in the near future have made investors wary of high-risk technology stocks, including those held by ARK funds.</p><p>Just last week, Wood told subscribers to her stock commentary that “volatility could persist until demand destruction and excess inventories make it clear that inflation is not entrenched in the economy.”</p><p>Additionally, a slate of disappointing earnings results have been a major factor in the recent drop. For instance, since the beginning of the year, the<b> ARK Innovation ETF</b>(NYSEARCA:<b><u>ARKK</u></b>) has fallen over 60%.</p><p>Yet, innovation remains the primary driving force in the global economy.<b>McKinsey & Co.</b> suggests, “Innovation is critical to growth, particularly as the speed of business cycles continues to increase.”</p><p>Despite recent losses, robust companies in Wood’s portfolio could potentially bounce back in the coming months. With that in mind, here are three of the best of Cathie Wood stocks to buy in May.</p><p>Block (SQ)</p><p>Our first Cathie Wood stock pick is the financial technology (fintech) name <b>Block</b>(NYSE:<b><u>SQ</u></b>). Formerly known as Square, Block’s products include the Square payment system, Cash App, Afterpay, Weebly and TIDAL.</p><p>In early May, Block published first-quarter results. Total net revenue was $3.96 billion, down from $5.06 billion the year before. This decline of 22% year-over-year (YOY) was mainly due to the inclusion its <b>Bitcoin</b>(<b><u>BTC-USD</u></b>) activity. Excluding bitcoin revenue, revenue increased 44% YOY to $2.23 billion. The net loss per diluted share came in at 38 cents, compared to a net income of 8 cents per diluted share a year ago.</p><p>Recently, the company announced the launch of Square Loans in Canada. This service has distributed around $9 billion in loans to small businesses in the U.S. and Australia, where it has been active since 2014. Moreover, the company announced the introduction of a new generation of the Square Stand, the point-of-sale system that increases efficiency and transparency.</p><p>While more than 11% of <b>ARK Fintech Innovation ETF</b> (NYSEARCA:<b><u>ARKF</u></b>) is allocated to SQ stock, theARK Innovation ETF, ARKK, leads the pack as the Wood-led fund with the most Square shares.</p><p>SQ stock is down over 55% year-to-date. Yet despite the decline, shares are trading at 101 times forward earnings and 2.7 times trailing sales. Meanwhile. the 12-month median for Square stock forecast is at$150.00.</p><p>CRISPR Therapeutics<b>(CRSP)</b></p><p>Next up on our list of Cathie Wood stocks is the biotech name <b>CRISPR Therapeutics</b>(NASDAQ:CRSP). Analysts concur that it has revolutionized the field of genetic engineering by providing a fast, precise, and relatively inexpensive method for gene manipulation.</p><p>In mid-February, the company releasedQ4 FY21results. Revenue increased to $12.9 million, up from $370,000 in the prior-year period. Loss per diluted share came in at $1.84, compared to net income per share of $1.50 in the prior-year quarter. Cash and equivalents ended 2021 at$2.38 billion.</p><p>Recently, the company has announced significant progress in clinical trials for the treatments for Type I diabetes, cancer, and ALS. These trials represent partnerships with notable biotechnology companies and pave the way for eventual distribution to the market.</p><p>Among ARK ETFs, theARK Innovation ETF stands out as the one with the most CRSP shares.</p><p>So far in the year, the stock is down over 42%. Meanwhile, shares are trading at 23.6x forward earnings and 4.5x trailing sales. At present, the 12-month median forecast for CRSP stock is$143.00.</p><p><b>Shopify (SHOP)</b></p><p>The final single stock on our list is <b>Shopify</b> (NYSE:<b><u>SHOP</u></b>), the multinational all-in-one e-commerce solution provider. This Canada-based tech giant offers a variety of tools for independent business owners. Services include logo design, online payment services, web design, logistics, and domain name registration.</p><p>In early May, Shopify reported its Q1 FY22results. Revenue came in at $1.20 billion, up 22% YOY. Diluted earnings per share (EPS) was 20 cents. In the year before, it had been $2.01. Cash and equivalents ended the quarter at $7.25 billion.</p><p>The e-commerce giant recently announced it had reached an agreement to acquire <b>Deliverr</b>, an e-commerce fulfillment, and logistics company. This transaction is expected to strengthen Shopify’s delivery systems, improve infrastructure, as well as shorten delivery times.</p><p>Readers would be interested to know that theARK Innovation ETF also stands out as the ARK fund with the highest amount of shares.</p><p>SHOP stock is down 73% YTD. Forward price-to-earnings and price-to-sales ratios stand at 175x and 11.4x, respectively. Finally, the 12-month median forecast for SHOP stock is currently at$527.50.</p><p><b>ARK Autonomous Technology & Robotics ETF (ARKQ)</b></p><p>Our next two choices are two exchange-traded funds managed by Cathie Wood. First up is the <b>ARK Autonomous Technology & Robotics ETF</b>(NYSEARCA:<b><u>ARKQ</u></b>). It invests in global companies that benefit from disruptive technologies, such as artificial intelligence (AI), automation, and robotics.</p><p>This actively managed fund has amassed net assets of$1.6 billion since its inception in September 2014. Its annual expense ratio stands at 0.75% per year.</p><p>ARKQtypically has 30 – 50 holdings. At the time of writing, it holds 39 stocks, of which the top 10 names account for almost 60% of the portfolio.</p><p>Among those are <b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>); technology solutions provider <b>Trimble</b>(NASDAQ:<b><u>TRMB</u></b>);<b>Kratos Defense and Security Solutions</b>(NASDAQ:<b><u>KTOS</u></b>); Japanese construction equipment manufacturer <b>Komatsu</b>(OTCMKTS:<b><u>KMTUY</u></b>); and <b>UiPath</b>(NYSE:<b><u>PATH</u></b>), provider of end-to-end platform for automation.</p><p>Autonomous vehicles have the biggest share (40.4%) of the fund’s technological exposure. Next are 3D Printing (17.2%) and robotics (16.4%).</p><p>With regards to the sector allocations, the fund is heavily weighted toward industrials (42.6%), followed by information technology (28.9%) and consumer discretionary (19.4%).</p><p>ARKQ stock has been in a downtrend since seeing record highs in November 2021. The ETF hit a 52-week low on May 9. It has also underperformed the broader market with a loss of about 37% since January and 39% over the past 52 weeks.</p><p>However, despite the potential setbacks by inflationary headwinds, the growth prospects of the robotics and autonomy industry appear strong. Thus, investors might want to keep ARKQ stock on the radar to buy the dips.</p><p><b>ARK Space Exploration & Innovation ETF (ARKX)</b></p><p>Our final discussion centers around the <b>ARK Space Exploration & Innovation ETF</b>(NYSEARCA:<b><u>ARKX</u></b>), which focuses on the space-related industry. It invests in global firms at the forefront or space-related activities or technologies.</p><p>The fund, which was launched in March 2021, typically holds 35 – 55 stocks.It currently has a portfolio of 35 holdings and total net assets of around $421 million. Its expense ratio is also 0.75%.</p><p>Industrials lead the way with 57.2%. Next are IT (22.7%) and communication services (7.4%). The actively managed ETF currently invests heavily in aerospace beneficiary companies (43.3%) that are engaged in agri-science, internet access, global positioning systems (GPS), construction, drones, or electric aviation vehicles.</p><p>The fund has around 60% of its investments in the top 10 stocks.The largest holding,<b>Trimble</b> comprises almost 10% of the portfolio. Next come Kratos Defense and Security Solutions; the<b>3D Printing ETF</b>(NYSEARCA:<b><u>PRNT</u></b>); <b>L3harris Technologies</b>(NYSE:<b><u>LHX</u></b>); and <b>AeroVironment</b>(NASDAQ:<b><u>AVAV</u></b>).</p><p>ARKX stock is down around 28% YTD and 33% over the past 12 months. It hit a 52-week low in recent days.</p><p>Nonetheless, the global space industry prospects look bright as new players and emerging technologies are opening it as the new frontier. Thus, risk-tolerant investors with a horizon of three-to-five years could consider investing in ARKX using a small portion of their investment portfolios.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Cathie Wood Stocks to Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Cathie Wood Stocks to Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-17 23:29 GMT+8 <a href=https://investorplace.com/2022/05/5-cathie-wood-stocks-to-buy-now-sq-crsp-shop-arkq-arkx/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite recent declines in share prices, these Cathie Wood stocks are strong plays on innovation, a key driver of the global economy.Block(SQ) — The launch of Square Loans in Canada as well as the new...</p>\n\n<a href=\"https://investorplace.com/2022/05/5-cathie-wood-stocks-to-buy-now-sq-crsp-shop-arkq-arkx/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SHOP":"Shopify Inc","ARKX":"ARK Space Exploration & Innovation ETF","SQ":"Block","CRSP":"CRISPR Therapeutics AG","ARKQ":"ARK Autonomous Technology & Robotics ETF"},"source_url":"https://investorplace.com/2022/05/5-cathie-wood-stocks-to-buy-now-sq-crsp-shop-arkq-arkx/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150378774","content_text":"Despite recent declines in share prices, these Cathie Wood stocks are strong plays on innovation, a key driver of the global economy.Block(SQ) — The launch of Square Loans in Canada as well as the new generation of the Square Stand could provide a significant path to revenue growth.CRISPR Therapeutics(CRSP) — Substantial global investment in genetic engineering is likely to pave the way for tremendous growth.Shopify(SHOP) — The recent acquisition of Deliverr is likely to improve logistics operations and increase efficiency.ARK Autonomous Technology & Robotics ETF(ARKQ) — The exchange-traded fund, which has lost over a third of its value in 2022, offers better opportunities now.ARK Space Exploration & Innovation ETF(ARKX) — The fund invests in firms that are at the forefront of aerospace and space-related technologies.Cathie Wood stocks, our topic for today, have come under fire in 2022. Yet, during the pandemic, ARK Invest funds, led by Wood’s team, had generated tremendous buzz on Wall Street. The firm’s exchange-traded funds (ETFs), which seek long-term capital growth, focus mainly on disruptive innovation.However, 2022 has proved a tough year for such high-growth shares. Concerns over the possibility of a recession in the near future have made investors wary of high-risk technology stocks, including those held by ARK funds.Just last week, Wood told subscribers to her stock commentary that “volatility could persist until demand destruction and excess inventories make it clear that inflation is not entrenched in the economy.”Additionally, a slate of disappointing earnings results have been a major factor in the recent drop. For instance, since the beginning of the year, the ARK Innovation ETF(NYSEARCA:ARKK) has fallen over 60%.Yet, innovation remains the primary driving force in the global economy.McKinsey & Co. suggests, “Innovation is critical to growth, particularly as the speed of business cycles continues to increase.”Despite recent losses, robust companies in Wood’s portfolio could potentially bounce back in the coming months. With that in mind, here are three of the best of Cathie Wood stocks to buy in May.Block (SQ)Our first Cathie Wood stock pick is the financial technology (fintech) name Block(NYSE:SQ). Formerly known as Square, Block’s products include the Square payment system, Cash App, Afterpay, Weebly and TIDAL.In early May, Block published first-quarter results. Total net revenue was $3.96 billion, down from $5.06 billion the year before. This decline of 22% year-over-year (YOY) was mainly due to the inclusion its Bitcoin(BTC-USD) activity. Excluding bitcoin revenue, revenue increased 44% YOY to $2.23 billion. The net loss per diluted share came in at 38 cents, compared to a net income of 8 cents per diluted share a year ago.Recently, the company announced the launch of Square Loans in Canada. This service has distributed around $9 billion in loans to small businesses in the U.S. and Australia, where it has been active since 2014. Moreover, the company announced the introduction of a new generation of the Square Stand, the point-of-sale system that increases efficiency and transparency.While more than 11% of ARK Fintech Innovation ETF (NYSEARCA:ARKF) is allocated to SQ stock, theARK Innovation ETF, ARKK, leads the pack as the Wood-led fund with the most Square shares.SQ stock is down over 55% year-to-date. Yet despite the decline, shares are trading at 101 times forward earnings and 2.7 times trailing sales. Meanwhile. the 12-month median for Square stock forecast is at$150.00.CRISPR Therapeutics(CRSP)Next up on our list of Cathie Wood stocks is the biotech name CRISPR Therapeutics(NASDAQ:CRSP). Analysts concur that it has revolutionized the field of genetic engineering by providing a fast, precise, and relatively inexpensive method for gene manipulation.In mid-February, the company releasedQ4 FY21results. Revenue increased to $12.9 million, up from $370,000 in the prior-year period. Loss per diluted share came in at $1.84, compared to net income per share of $1.50 in the prior-year quarter. Cash and equivalents ended 2021 at$2.38 billion.Recently, the company has announced significant progress in clinical trials for the treatments for Type I diabetes, cancer, and ALS. These trials represent partnerships with notable biotechnology companies and pave the way for eventual distribution to the market.Among ARK ETFs, theARK Innovation ETF stands out as the one with the most CRSP shares.So far in the year, the stock is down over 42%. Meanwhile, shares are trading at 23.6x forward earnings and 4.5x trailing sales. At present, the 12-month median forecast for CRSP stock is$143.00.Shopify (SHOP)The final single stock on our list is Shopify (NYSE:SHOP), the multinational all-in-one e-commerce solution provider. This Canada-based tech giant offers a variety of tools for independent business owners. Services include logo design, online payment services, web design, logistics, and domain name registration.In early May, Shopify reported its Q1 FY22results. Revenue came in at $1.20 billion, up 22% YOY. Diluted earnings per share (EPS) was 20 cents. In the year before, it had been $2.01. Cash and equivalents ended the quarter at $7.25 billion.The e-commerce giant recently announced it had reached an agreement to acquire Deliverr, an e-commerce fulfillment, and logistics company. This transaction is expected to strengthen Shopify’s delivery systems, improve infrastructure, as well as shorten delivery times.Readers would be interested to know that theARK Innovation ETF also stands out as the ARK fund with the highest amount of shares.SHOP stock is down 73% YTD. Forward price-to-earnings and price-to-sales ratios stand at 175x and 11.4x, respectively. Finally, the 12-month median forecast for SHOP stock is currently at$527.50.ARK Autonomous Technology & Robotics ETF (ARKQ)Our next two choices are two exchange-traded funds managed by Cathie Wood. First up is the ARK Autonomous Technology & Robotics ETF(NYSEARCA:ARKQ). It invests in global companies that benefit from disruptive technologies, such as artificial intelligence (AI), automation, and robotics.This actively managed fund has amassed net assets of$1.6 billion since its inception in September 2014. Its annual expense ratio stands at 0.75% per year.ARKQtypically has 30 – 50 holdings. At the time of writing, it holds 39 stocks, of which the top 10 names account for almost 60% of the portfolio.Among those are Tesla(NASDAQ:TSLA); technology solutions provider Trimble(NASDAQ:TRMB);Kratos Defense and Security Solutions(NASDAQ:KTOS); Japanese construction equipment manufacturer Komatsu(OTCMKTS:KMTUY); and UiPath(NYSE:PATH), provider of end-to-end platform for automation.Autonomous vehicles have the biggest share (40.4%) of the fund’s technological exposure. Next are 3D Printing (17.2%) and robotics (16.4%).With regards to the sector allocations, the fund is heavily weighted toward industrials (42.6%), followed by information technology (28.9%) and consumer discretionary (19.4%).ARKQ stock has been in a downtrend since seeing record highs in November 2021. The ETF hit a 52-week low on May 9. It has also underperformed the broader market with a loss of about 37% since January and 39% over the past 52 weeks.However, despite the potential setbacks by inflationary headwinds, the growth prospects of the robotics and autonomy industry appear strong. Thus, investors might want to keep ARKQ stock on the radar to buy the dips.ARK Space Exploration & Innovation ETF (ARKX)Our final discussion centers around the ARK Space Exploration & Innovation ETF(NYSEARCA:ARKX), which focuses on the space-related industry. It invests in global firms at the forefront or space-related activities or technologies.The fund, which was launched in March 2021, typically holds 35 – 55 stocks.It currently has a portfolio of 35 holdings and total net assets of around $421 million. Its expense ratio is also 0.75%.Industrials lead the way with 57.2%. Next are IT (22.7%) and communication services (7.4%). The actively managed ETF currently invests heavily in aerospace beneficiary companies (43.3%) that are engaged in agri-science, internet access, global positioning systems (GPS), construction, drones, or electric aviation vehicles.The fund has around 60% of its investments in the top 10 stocks.The largest holding,Trimble comprises almost 10% of the portfolio. Next come Kratos Defense and Security Solutions; the3D Printing ETF(NYSEARCA:PRNT); L3harris Technologies(NYSE:LHX); and AeroVironment(NASDAQ:AVAV).ARKX stock is down around 28% YTD and 33% over the past 12 months. It hit a 52-week low in recent days.Nonetheless, the global space industry prospects look bright as new players and emerging technologies are opening it as the new frontier. Thus, risk-tolerant investors with a horizon of three-to-five years could consider investing in ARKX using a small portion of their investment portfolios.","news_type":1},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9960124975,"gmtCreate":1668116341298,"gmtModify":1676538013505,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a><v-v data-views=\"1\"></v-v>[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"$Novavax(NVAX)$ [Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9960124975","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9919757956,"gmtCreate":1663882880076,"gmtModify":1676537353471,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9919757956","repostId":"1158145778","repostType":2,"repost":{"id":"1158145778","kind":"news","pubTimestamp":1663857071,"share":"https://ttm.financial/m/news/1158145778?lang=&edition=fundamental","pubTime":"2022-09-22 22:31","market":"us","language":"en","title":"Why Is Novavax Stock Falling Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1158145778","media":"InvestorPlace","summary":"Novavax(NVAX) is dropping after a negative analyst report.The company finished third in the race for","content":"<html><head></head><body><ul><li><b>Novavax</b>(<b>NVAX</b>) is dropping after a negative analyst report.</li><li>The company finished third in the race for a Covid-19 vaccine.</li><li>Investors should have seen this coming.</li></ul><p><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>) stock fell 6% on Sept. 21, and kept falling overnight, after a JP Morgan Chase analyst cut his price target from over $100/share down to just $27 with an “underperform” rating.</p><p>Eric Joseph said the action came after he revised the bank’s outlook for Novavax’s Covid-19 vaccine, called Nuvaxovid.</p><p>Shares trading at nearly $27.40 early on Sept. 21 were now trading at a little over $24 early on Sept. 22. Novavax’s market capitalization is now a little under $2 billion, and is down 90% on the year.</p><p><b>What Happened?</b></p><p>Novavax was a 2020 Covid-19 star on hopes for its vaccine, as developed with money from the Gates Foundation and the U.S. government. The company said then that its Matrix-M adjuvant would let it quickly ramp up production on a vaccine that wouldn’t require special handling.</p><p>But Novavaxfinished third in the vaccine race to MRNA-based solutions from <b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which got its technology from <b>BionTech SE</b>(NASDAQ:<b><u>BNTX</u></b>) of Germany, and <b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>). By this past April,I was calling the stock’s party over. At that time the stock was trading at $62 but most analysts, like the one from JP Morgan, still rated it highly.</p><p>Novavax has other vaccines in its pipeline, including one for the seasonal flu. But it has been unable to win approval in the past and lacks orders. Analysts now call ita risk-on stock in a risk-off market. Onlysixeven tell<i>Tipranks</i>they follow it now and all their forecasts look dated.</p><p><b>NVAX Stock: What Happens Now</b></p><p>Before the Covid-19 pandemic began, Novavax wasa $5/share stock. It could be headed there again.</p><p>The company ended June with about $1.4 billion in the bank, but operating cash flow has been negative for four straight quarters, which seems unlikely to change. It needs to conserve that cash and win approval for its flu vaccine.</p></body></html>","source":"investorplace","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is Novavax Stock Falling Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is Novavax Stock Falling Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 22:31 GMT+8 <a href=https://investorplace.com/2022/09/why-is-novavax-nvax-stock-falling-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax(NVAX) is dropping after a negative analyst report.The company finished third in the race for a Covid-19 vaccine.Investors should have seen this coming.Novavax(NASDAQ:NVAX) stock fell 6% on ...</p>\n\n<a href=\"https://investorplace.com/2022/09/why-is-novavax-nvax-stock-falling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2022/09/why-is-novavax-nvax-stock-falling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158145778","content_text":"Novavax(NVAX) is dropping after a negative analyst report.The company finished third in the race for a Covid-19 vaccine.Investors should have seen this coming.Novavax(NASDAQ:NVAX) stock fell 6% on Sept. 21, and kept falling overnight, after a JP Morgan Chase analyst cut his price target from over $100/share down to just $27 with an “underperform” rating.Eric Joseph said the action came after he revised the bank’s outlook for Novavax’s Covid-19 vaccine, called Nuvaxovid.Shares trading at nearly $27.40 early on Sept. 21 were now trading at a little over $24 early on Sept. 22. Novavax’s market capitalization is now a little under $2 billion, and is down 90% on the year.What Happened?Novavax was a 2020 Covid-19 star on hopes for its vaccine, as developed with money from the Gates Foundation and the U.S. government. The company said then that its Matrix-M adjuvant would let it quickly ramp up production on a vaccine that wouldn’t require special handling.But Novavaxfinished third in the vaccine race to MRNA-based solutions from Pfizer(NYSE:PFE), which got its technology from BionTech SE(NASDAQ:BNTX) of Germany, and Moderna(NASDAQ:MRNA). By this past April,I was calling the stock’s party over. At that time the stock was trading at $62 but most analysts, like the one from JP Morgan, still rated it highly.Novavax has other vaccines in its pipeline, including one for the seasonal flu. But it has been unable to win approval in the past and lacks orders. Analysts now call ita risk-on stock in a risk-off market. Onlysixeven tellTipranksthey follow it now and all their forecasts look dated.NVAX Stock: What Happens NowBefore the Covid-19 pandemic began, Novavax wasa $5/share stock. It could be headed there again.The company ended June with about $1.4 billion in the bank, but operating cash flow has been negative for four straight quarters, which seems unlikely to change. It needs to conserve that cash and win approval for its flu vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9931311702,"gmtCreate":1662413667506,"gmtModify":1676537052091,"author":{"id":"4090807166052950","authorId":"4090807166052950","name":"GangKK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090807166052950","authorIdStr":"4090807166052950"},"themes":[],"htmlText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","listText":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] ","text":"[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9931311702","repostId":"2265084019","repostType":2,"repost":{"id":"2265084019","kind":"highlight","pubTimestamp":1662429670,"share":"https://ttm.financial/m/news/2265084019?lang=&edition=fundamental","pubTime":"2022-09-06 10:01","market":"us","language":"en","title":"What to Expect From Apple’s iPhone 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2265084019","media":"The Australian Financial Review","summary":"Apple’s launch later this week of the iPhone 14 could have the unintended consequence of driving con","content":"<html><head></head><body><p>Apple’s launch later this week of the iPhone 14 could have the unintended consequence of driving consumers to older iPhone models if Apple is not careful, an analyst has warned.</p><p>The new generation of iPhones, which is expected to be announced on Thursday morning as part of Apple’s “Far Out” event in California, is widely expected to be similar to the current iPhone 13 generation. The main difference is Apple is rumoured to have removed the unpopular “notch” from the top of the iPhone 14 Pro’s screen, and replaced it with smaller cutouts for the phone’s front camera and Face ID system.</p><p>Apple’s next iPhone is rumoured to have done away with the unpopular notch, and replaced it with the cutouts favoured by Android phones.</p><p>In the middle of an economic downturn, such a marginal upgrade could drive consumers to eschew the new model and take advantage of the price cuts to existing models, which inevitably occur when Apple introduces a new phone, said Foad Fadaghi, managing director of analyst outfit Telsyte.</p><p>“Older models tend to do well once they get superseded, and they get a price drop. It’s an open question whether the iPhone 14 will be a hit, or whether consumers will look at an iPhone 13 and think to themselves ‘It looks exactly the same, I prefer that for a lower price’,” he told <i>The Australian Financial Review</i>.</p><p>The regular iPhone 14 is rumoured to be similar to the iPhone 13 internally, as well as in appearance.</p><p>While some insiders are predicting the entire iPhone 14 range will have the same A15 Bionic processor as the iPhone 13, others expect Apple to introduce a new processor, the A16 Bionic, but only for the iPhone 14 Pro and Pro Max phones, to help justify the $500 or more extra that Apple charges for Pro models.</p><p>It is even expected that the biggest cosmetic change, the removal of the notch, will only apply to Pro models, leaving the regular iPhone 14 almost indistinguishable from the iPhone 13, apart from new colours that Apple is expected to introduce. There is also a possibility of a larger camera bump at the back, to accommodate more powerful cameras.</p><p>Apple CEO Tim Cook announced the iPhone 13, notch and all, last September. It could be the big winner from the iPhone 14 launch this September.</p><p>Whichever phones have their notch removed, the latest rumours suggest the notch will be replaced by two, small cutouts in the screen – a round one for the camera, and a larger one for the Face ID biometric scanner – but that Apple has decided to turn off all the pixels in the screen between the two cutouts, to make it appear as a single, long cutout that’s less distracting than two smaller ones.</p><p>But, regardless of the mix of iPhone 13 and iPhone 14 sales in coming months, Apple should still do well out of the launch, Mr Fadaghi said.</p><p>According to Telsyte’s Australian Smartphone & Wearable Devices Market Study 2022-26<i>, </i>Australian sales of the iPhone were down by 2 per cent in the first half of this year, compared to the same half last year. Over the same period, sales of Android phones were up by 5 per cent.</p><p>But that small decline in iPhone sales was influenced by one-off factors, such as Apple extending the life of older models and users having previously brought forward the phone upgrades in the early days of the COVID-19 pandemic, and Australian sales should rebound in this half, Mr Fadaghi said.</p><p>Including Android and iPhone sales, Australians are expected to buy 4.6 million phones in the second half of 2022, an increase of 3 per cent over the same period last year, Telsyte found.</p><p>Looking ahead, though, Apple does need to come out with some sort of foldable iPhone, to counter the growing popularity of Samsung’s Galaxy Z Fold and Galaxy Z Flip phones.</p><p>Telsyte’s study found that 6 per cent of Android phones sold in the first half of 2022 were foldable – a trend that is only going to accelerate in the coming year, when roughly one in eight Android phones sold will be foldable.</p><p>“Apple needs to respond to the folding challenge in the next year or two,” Mr Fadaghi said. Folding phones are starting to become popular with social media influencers, who find that having a second screen on the phone allows them to take selfies with the phone’s rear camera, which takes better photos than the front camera.</p><p>“There are a few use cases for folding phones that present a challenge for Apple, and one of them is influencers. Apple needs to do something to shore up its popularity among influencers,” Mr Fadaghi said.</p></body></html>","source":"afr_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What to Expect From Apple’s iPhone 14</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat to Expect From Apple’s iPhone 14\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-06 10:01 GMT+8 <a href=https://www.afr.com/technology/what-to-expect-from-apple-s-iphone-14-20220902-p5bex7><strong>The Australian Financial Review</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple’s launch later this week of the iPhone 14 could have the unintended consequence of driving consumers to older iPhone models if Apple is not careful, an analyst has warned.The new generation of ...</p>\n\n<a href=\"https://www.afr.com/technology/what-to-expect-from-apple-s-iphone-14-20220902-p5bex7\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.afr.com/technology/what-to-expect-from-apple-s-iphone-14-20220902-p5bex7","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2265084019","content_text":"Apple’s launch later this week of the iPhone 14 could have the unintended consequence of driving consumers to older iPhone models if Apple is not careful, an analyst has warned.The new generation of iPhones, which is expected to be announced on Thursday morning as part of Apple’s “Far Out” event in California, is widely expected to be similar to the current iPhone 13 generation. The main difference is Apple is rumoured to have removed the unpopular “notch” from the top of the iPhone 14 Pro’s screen, and replaced it with smaller cutouts for the phone’s front camera and Face ID system.Apple’s next iPhone is rumoured to have done away with the unpopular notch, and replaced it with the cutouts favoured by Android phones.In the middle of an economic downturn, such a marginal upgrade could drive consumers to eschew the new model and take advantage of the price cuts to existing models, which inevitably occur when Apple introduces a new phone, said Foad Fadaghi, managing director of analyst outfit Telsyte.“Older models tend to do well once they get superseded, and they get a price drop. It’s an open question whether the iPhone 14 will be a hit, or whether consumers will look at an iPhone 13 and think to themselves ‘It looks exactly the same, I prefer that for a lower price’,” he told The Australian Financial Review.The regular iPhone 14 is rumoured to be similar to the iPhone 13 internally, as well as in appearance.While some insiders are predicting the entire iPhone 14 range will have the same A15 Bionic processor as the iPhone 13, others expect Apple to introduce a new processor, the A16 Bionic, but only for the iPhone 14 Pro and Pro Max phones, to help justify the $500 or more extra that Apple charges for Pro models.It is even expected that the biggest cosmetic change, the removal of the notch, will only apply to Pro models, leaving the regular iPhone 14 almost indistinguishable from the iPhone 13, apart from new colours that Apple is expected to introduce. There is also a possibility of a larger camera bump at the back, to accommodate more powerful cameras.Apple CEO Tim Cook announced the iPhone 13, notch and all, last September. It could be the big winner from the iPhone 14 launch this September.Whichever phones have their notch removed, the latest rumours suggest the notch will be replaced by two, small cutouts in the screen – a round one for the camera, and a larger one for the Face ID biometric scanner – but that Apple has decided to turn off all the pixels in the screen between the two cutouts, to make it appear as a single, long cutout that’s less distracting than two smaller ones.But, regardless of the mix of iPhone 13 and iPhone 14 sales in coming months, Apple should still do well out of the launch, Mr Fadaghi said.According to Telsyte’s Australian Smartphone & Wearable Devices Market Study 2022-26, Australian sales of the iPhone were down by 2 per cent in the first half of this year, compared to the same half last year. Over the same period, sales of Android phones were up by 5 per cent.But that small decline in iPhone sales was influenced by one-off factors, such as Apple extending the life of older models and users having previously brought forward the phone upgrades in the early days of the COVID-19 pandemic, and Australian sales should rebound in this half, Mr Fadaghi said.Including Android and iPhone sales, Australians are expected to buy 4.6 million phones in the second half of 2022, an increase of 3 per cent over the same period last year, Telsyte found.Looking ahead, though, Apple does need to come out with some sort of foldable iPhone, to counter the growing popularity of Samsung’s Galaxy Z Fold and Galaxy Z Flip phones.Telsyte’s study found that 6 per cent of Android phones sold in the first half of 2022 were foldable – a trend that is only going to accelerate in the coming year, when roughly one in eight Android phones sold will be foldable.“Apple needs to respond to the folding challenge in the next year or two,” Mr Fadaghi said. Folding phones are starting to become popular with social media influencers, who find that having a second screen on the phone allows them to take selfies with the phone’s rear camera, which takes better photos than the front camera.“There are a few use cases for folding phones that present a challenge for Apple, and one of them is influencers. Apple needs to do something to shore up its popularity among influencers,” Mr Fadaghi said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":26,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}